Loading...
Header Logo
Keywords
Last Name
Institution

ADEL K EL-NAGGAR

TitleProfessor
InstitutionMD Anderson
DepartmentPathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch. 2019 Aug 19. PMID: 31423558.
      View in: PubMed
    2. Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY. Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2019 Aug 01; 25(15):4861. PMID: 31371311.
      View in: PubMed
    3. Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN. Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clin Cancer Res. 2019 Aug 01; 25(15):4862. PMID: 31371312.
      View in: PubMed
    4. Saluja K, Ravishankar S, Ferrarotto R, Zhu H, Pytynia KB, El-Naggar AK. Ectopic ACTH Production and Cushing's Syndrome in a Patient with Parotid Acinic Cell Carcinoma with High-Grade Transformation: Tumor Context and Clinical Implications. Head Neck Pathol. 2019 Jul 30. PMID: 31363907.
      View in: PubMed
    5. Aryal NK, Pant V, Wasylishen AR, Rimel BJ, Baseler L, El-Naggar AK, Mutch DG, Goodfellow PJ, Arur S, Lozano G. Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination. Cancer Res. 2019 May 15; 79(10):2662-2668. PMID: 30914430.
      View in: PubMed
    6. Nikiforova MN, Nikitski AV, Panebianco F, Kaya C, Yip L, Williams M, Chiosea SI, Seethala RR, Roy S, Condello V, Santana-Santos L, Wald AI, Carty SE, Ferris RL, El-Naggar AK, Nikiforov YE. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland. Thyroid. 2019 02; 29(2):161-173. PMID: 30648929.
      View in: PubMed
    7. Aryal NK, Pant V, Wasylishen AR, Parker-Thornburg J, Baseler L, El-Naggar AK, Liu B, Kalia A, Lozano G, Arur S. Constitutive Dicer1 phosphorylation accelerates metabolism and aging in vivo. Proc Natl Acad Sci U S A. 2019 01 15; 116(3):960-969. PMID: 30593561.
      View in: PubMed
    8. Ibrahim MY, Nunez MI, Harun N, Lee JJ, El-Naggar AK, Ferrarotto R, Wistuba I, Myers J, Glisson BS, William WN. PI3-kinase pathway biomarkers in oral cancer and tumor immune cells. Head Neck. 2019 Mar; 41(3):615-622. PMID: 30556200.
      View in: PubMed
    9. Zhang Y, Xiong S, Liu B, Pant V, Celii F, Chau G, Elizondo-Fraire AC, Yang P, You MJ, El-Naggar AK, Navin NE, Lozano G. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases. Nat Commun. 2018 09 27; 9(1):3953. PMID: 30262850.
      View in: PubMed
    10. Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, Kies MS, Maity SN, Lin SH, El-Naggar AK. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 2018 09 15; 124(18):3693-3705. PMID: 30289966.
      View in: PubMed
    11. Ileana Dumbrava E, Smith V, Alfattal R, El-Naggar AK, Penas-Prado M, Tsimberidou AM. Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy. J Immunother. 2018 09; 41(7):336-339. PMID: 29787423.
      View in: PubMed
    12. Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018 12; 31(12):1770-1786. PMID: 30140036.
      View in: PubMed
    13. Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj SA, Sheu T, El-Naggar AK, Fuller CD, Weber RS, Lai SY. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck. 2018 08; 40(8):1630-1638. PMID: 29734482.
      View in: PubMed
    14. Kakudo K, El-Naggar AK, Hodak SP, Khanafshar E, Nikiforov YE, Nosé V, Thompson LDR. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in thyroid tumor classification. Pathol Int. 2018 06; 68(6):327-333. PMID: 29675873.
      View in: PubMed
    15. Saintigny P, William WN, Foy JP, Papadimitrakopoulou V, Lang W, Zhang L, Fan YH, Feng L, Kim ES, El-Naggar AK, Lee JJ, Mao L, Hong WK, Lingen MW, Lippman SM. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3). PMID: 29617836.
      View in: PubMed
    16. Rito M, Mitani Y, Bell D, Mariano FV, Almalki ST, Pytynia KB, Fonseca I, El-Naggar AK. Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression. Mod Pathol. 2018 07; 31(7):1064-1072. PMID: 29463883.
      View in: PubMed
    17. Larsson CA, Moyer SM, Liu B, Michel KA, Pant V, Yang P, Wong J, El-Naggar AK, Krahe R, Lozano G. Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration. Proc Natl Acad Sci U S A. 2018 02 27; 115(9):2198-2203. PMID: 29440484.
      View in: PubMed
    18. Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol. 2018 04; 79:1-8. PMID: 29598944.
      View in: PubMed
    19. Frerich CA, Brayer KJ, Painter BM, Kang H, Mitani Y, El-Naggar AK, Ness SA. Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes. Oncotarget. 2018 Jan 26; 9(7):7341-7358. PMID: 29484115.
      View in: PubMed
    20. Saluja K, Thomas J, Zhang S, Sturgis EM, Jain KS, Prieto VG, El-Naggar AK, Bell D. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. Hum Pathol. 2018 06; 76:149-155. PMID: 29208563.
      View in: PubMed
    21. Thakar SD, Sagiv O, Tetzlaff MT, El-Naggar A, Debnam JM, Kandl TJ, Esmaeli B. A 60-year-old woman with an asymptomatic left lacrimal gland mass found incidentally. Digit J Ophthalmol. 2017; 23(4):27-29. PMID: 29403339.
      View in: PubMed
    22. Wang J, Xie T, Wang B, William WN, Heymach JV, El-Naggar AK, Myers JN, Caulin C. PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions. Cancer Prev Res (Phila). 2017 Dec; 10(12):684-693. PMID: 29018057.
      View in: PubMed
    23. Liu B, Mitani Y, Rao X, Zafereo M, Zhang J, Zhang J, Futreal PA, Lozano G, El-Naggar AK. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma. J Natl Cancer Inst. 2017 10 01; 109(10). PMID: 29117356.
      View in: PubMed
    24. Zhang H, Kim S, Chen Z, Nannapaneni S, Chen AY, Moore CE, Sica G, Mosunjac M, Nguyen MLT, D'Souza G, Carey TE, Peterson LA, McHugh JB, Graham M, Komarck CM, Wolf GT, Walline HM, Bellile E, Riddell J, Pai SI, Sidransky D, Westra WH, William WN, Lee JJ, El-Naggar AK, Ferris RL, Seethala R, Grandis JR, Chen ZG, Saba NF, Shin DM. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. Head Neck. 2017 12; 39(12):2433-2443. PMID: 28945296.
      View in: PubMed
    25. Jiffar T, Yilmaz T, Lee J, Miller Y, Feng L, El-Naggar A, Kupferman ME. Brain derived neutrophic factor (BDNF) coordinates lympho-vascular metastasis through a fibroblast-governed paracrine axis in the tumor microenvironment. Cancer Cell Microenviron. 2017; 4(2). PMID: 28966935.
      View in: PubMed
    26. Rosenthal DI, Mohamed ASR, Garden AS, Morrison WH, El-Naggar AK, Kamal M, Weber RS, Fuller CD, Peters LJ. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):1002-1011. PMID: 28721881.
      View in: PubMed
    27. El-Naggar AK. What Is New in the World Health Organization 2017 Histopathology Classification? Curr Treat Options Oncol. 2017 07; 18(7):43. PMID: 28639231.
      View in: PubMed
    28. El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017 08; 66:10-12. PMID: 28583885.
      View in: PubMed
    29. Bell D, El-Naggar AK, Gidley PW. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch. 2017 Nov; 471(5):667-672. PMID: 28547535.
      View in: PubMed
    30. Saluja K, Butler RT, Pytynia KB, Zhao B, Karni RJ, Weber RS, El-Naggar AK. Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association. Hum Pathol. 2017 10; 68:189-192. PMID: 28499545.
      View in: PubMed
    31. Li J, Mitani Y, Rao PH, Perlaky L, Liu B, Weber RS, El-Naggar AK. Establishment and genomic characterization of primary salivary duct carcinoma cell line. Oral Oncol. 2017 06; 69:108-114. PMID: 28559013.
      View in: PubMed
    32. El-Naggar AK. Editor's perspective on the 4th edition of the WHO head and neck tumor classification. J Egypt Natl Canc Inst. 2017 06; 29(2):65-66. PMID: 28455004.
      View in: PubMed
    33. Weidhaas JB, Harris J, Schaue D, Chen AM, Chin R, Axelrod R, El-Naggar AK, Singh AK, Galloway TJ, Raben D, Wang D, Matthiesen C, Avizonis VN, Manon RR, Yumen O, Nguyen-Tan PF, Trotti A, Skinner H, Zhang Q, Ferris RL, Sidransky D, Chung CH. The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2017 Apr 01; 3(4):483-491. PMID: 28006059.
      View in: PubMed
    34. Salem A, Bell D, Sepesi B, Papadimitrakopoulou V, El-Naggar A, Moran CA, Kalhor N. Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature. Virchows Arch. 2017 Jun; 470(6):619-626. PMID: 28343305.
      View in: PubMed
    35. Panaccione A, Zhang Y, Mi Y, Mitani Y, Yan G, Prasad ML, McDonald WH, El-Naggar AK, Yarbrough WG, Ivanov SV. Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma. Oral Oncol. 2017 03; 66:38-45. PMID: 28249646.
      View in: PubMed
    36. Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-McKay P, Bell D, William WN, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, Munster P, Faoro L, Dupont J, Lee JJ, Futreal A, El-Naggar AK, Heymach JV. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol. 2017 Jan 20; 35(3):352-360. PMID: 27870570.
      View in: PubMed
    37. Li Z, Gonzalez CL, Wang B, Zhang Y, Mejia O, Katsonis P, Lichtarge O, Myers JN, El-Naggar AK, Caulin C. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H). J Pathol. 2016 10; 240(2):224-34. PMID: 27447534.
      View in: PubMed
    38. Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):687-699. PMID: 27727066.
      View in: PubMed
    39. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016 08 01; 2(8):1023-9. PMID: 27078145.
      View in: PubMed
    40. Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751. PMID: 27466789.
      View in: PubMed
    41. Sridharan V, Gjini E, Liao X, Chau NG, Haddad RI, Severgnini M, Hammerman P, El-Naggar A, Freeman GJ, Hodi FS, Rodig SJ, Dranoff G, Schoenfeld JD. Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunol Res. 2016 08; 4(8):679-87. PMID: 27312343.
      View in: PubMed
    42. Saluja K, Rao PH, Myers JN, El-Naggar AK. Novel t(1;3)(q21,p21) translocation in a basal cell adenocarcinoma of the parotid gland: potential association with tumorigenesis. Hum Pathol. 2016 08; 54:189-92. PMID: 27085552.
      View in: PubMed
    43. Skinner HD, Giri U, Yang L, Woo SH, Story MD, Pickering CR, Byers LA, Williams MD, El-Naggar A, Wang J, Diao L, Shen L, Fan YH, Molkentine DP, Beadle BM, Meyn RE, Myers JN, Heymach JV. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer. Clin Cancer Res. 2016 Sep 15; 22(18):4643-50. PMID: 27036135.
      View in: PubMed
    44. Zafereo ME, Xu L, Dahlstrom KR, Viamonte CA, El-Naggar AK, Wei Q, Li G, Sturgis EM. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016 May; 56:47-53. PMID: 27086486.
      View in: PubMed
    45. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1117-31. PMID: 27354127.
      View in: PubMed
    46. William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16. PMID: 26540028.
      View in: PubMed
    47. Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, Faquin WC, Queimado L, Qi J, Wick MJ, El-Naggar AK, Bradner JE, Moskaluk CA, Aster JC, Knoechel B, Bernstein BE. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016 Mar; 48(3):265-72. PMID: 26829750.
      View in: PubMed
    48. Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res. 2016 Feb 01; 22(3):725-33. PMID: 26631609.
      View in: PubMed
    49. Nien HH, Sturgis EM, Kies MS, El-Naggar AK, Morrison WH, Beadle BM, Johnson FM, Gunn GB, Fuller CD, Phan J, Gold KA, Frank SJ, Skinner H, Rosenthal DI, Garden AS. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck. 2016 04; 38 Suppl 1:E1554-61. PMID: 26595157.
      View in: PubMed
    50. Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head Neck. 2016 04; 38 Suppl 1:E1459-66. PMID: 26560893.
      View in: PubMed
    51. Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):241-7. PMID: 26979544.
      View in: PubMed
    52. Perrier ND, El-Naggar AK. Editorial: How clinically significant is minimal extrathyroidal extension in papillary thyroid cancer? Surgery. 2016 Jan; 159(1):22. PMID: 26518390.
      View in: PubMed
    53. Wang Z, Ling S, Rettig E, Sobel R, Tan M, Fertig EJ, Considine M, El-Naggar AK, Brait M, Fakhry C, Ha PK. Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. Oral Oncol. 2015 Dec; 51(12):1120-5. PMID: 26490796.
      View in: PubMed
    54. Ragab Y, Nabih M, Aly I, Kamal A, Abd-Allah MA, El-Refai R, Emad Y, El-Naggar A, El-Shaarawy N, Rasker JJ. Magnetic resonance imaging features of hip disorders in an Egyptian pediatric population. Reumatismo. 2015 Sep 16; 67(2):68-77. PMID: 26492965.
      View in: PubMed
    55. Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prev Res (Phila). 2015 Nov; 8(11):1027-35. PMID: 26342026.
      View in: PubMed
    56. Bell D, Lewis C, El-Naggar AK, Weber RS. Primary intraosseous mucoepidermoid carcinoma of the jaw: Reappraisal of The MD Anderson Cancer Center experience. Head Neck. 2016 04; 38 Suppl 1:E1312-7. PMID: 26316332.
      View in: PubMed
    57. Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head Neck. 2016 04; 38 Suppl 1:E925-33. PMID: 25994561.
      View in: PubMed
    58. Xu L, Tang H, El-Naggar AK, Wei P, Sturgis EM. Genetic variants in DNA double-strand break repair genes and risk of salivary gland carcinoma: a case-control study. PLoS One. 2015; 10(6):e0128753. PMID: 26035306.
      View in: PubMed
    59. Bell D, Ferrarotto R, Fox MD, Roberts D, Hanna EY, Weber RS, El-Naggar AK. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther. 2015; 16(6):834-8. PMID: 25923130.
      View in: PubMed
    60. Huang AT, Tang C, Bell D, Yener M, Izquierdo L, Frank SJ, El-Naggar AK, Hanna EY, Weber RS, Kupferman ME. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5. PMID: 25843792.
      View in: PubMed
    61. Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar AK, Garden AS, Soulieres D, Trotti A, Avizonis VN, Ridge JA, Harris J, Le QT, Gillison M. Reply to B. O'Sullivan et Al. J Clin Oncol. 2015 May 20; 33(15):1708-9. PMID: 25823732.
      View in: PubMed
    62. Jakob JA, Kies MS, Glisson BS, Kupferman ME, Liu DD, Lee JJ, El-Naggar AK, Gonzalez-Angulo AM, Blumenschein GR. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck. 2015 May; 37(5):644-9. PMID: 24585506.
      View in: PubMed
    63. Xu L, Tang H, Chen DW, El-Naggar AK, Wei P, Sturgis EM. Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes. Cancer. 2015 Jul 15; 121(14):2367-74. PMID: 25823930.
      View in: PubMed
    64. William WN, El-Naggar AK. A novel target for oral cancer chemoprevention? Notch quite, yet…. Cancer Prev Res (Phila). 2015 Apr; 8(4):262-5. PMID: 25712052.
      View in: PubMed
    65. Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, El-Naggar A, Perrone F, Licitra L, Bossi P, Kimmel M, Frederick MJ, Lichtarge O, Myers JN. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Res. 2015 Apr 01; 75(7):1205-15. PMID: 25691460.
      View in: PubMed
    66. Quiroga-Garza G, Lee JH, El-Naggar A, Black JO, Amrikachi M, Zhai QJ, Ayala AG, Ro JY. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported. Hum Pathol. 2015 May; 46(5):725-31. PMID: 25754017.
      View in: PubMed
    67. Su YX, Roberts DB, Hanna EY, El-Naggar A, Saylam G, Frank SJ, Weber RS, Kupferman ME. Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. Ann Surg Oncol. 2015 Oct; 22(11):3701-7. PMID: 25636455.
      View in: PubMed
    68. Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, Beadle BM, El-Naggar AK, Kies MS, William WN, Caulin C, Frederick M, Kimmel M, Myers JN, Lichtarge O. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Res. 2015 Apr 01; 75(7):1527-36. PMID: 25634208.
      View in: PubMed
    69. Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, Morrison WH, Lewin JS, El-Naggar AK, Ginsberg LE, Kocak-Uzel E, Ang KK, Fuller CD. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Cancer. 2015 May 15; 121(10):1608-19. PMID: 25586197.
      View in: PubMed
    70. Shi X, Liu R, Qu S, Zhu G, Bishop J, Liu X, Sun H, Shan Z, Wang E, Luo Y, Yang X, Zhao J, Du J, El-Naggar AK, Teng W, Xing M. Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer. J Clin Endocrinol Metab. 2015 Apr; 100(4):E632-7. PMID: 25584719.
      View in: PubMed
    71. Yu YH, Morales J, Feng L, Lee JJ, El-Naggar AK, Vigneswaran N. CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 May; 119(5):553-65. PMID: 25747176.
      View in: PubMed
    72. Gao R, Cao C, Zhang M, Lopez MC, Yan Y, Chen Z, Mitani Y, Zhang L, Zajac-Kaye M, Liu B, Wu L, Renne R, Baker HV, El-Naggar A, Kaye FJ. A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets. Oncotarget. 2014 Dec 30; 5(24):12528-42. PMID: 25587024.
      View in: PubMed
    73. Henderson YC, Ahn SH, Ryu J, Chen Y, Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY, Clayman GL. Development and characterization of six new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 2015 Feb; 100(2):E243-52. PMID: 25427145.
      View in: PubMed
    74. El-Naggar AK. John G. Batsakis, MD (1929-2013): a historical perspective on his contributions to pathology. Arch Pathol Lab Med. 2014 Nov; 138(11):1424. PMID: 25357103.
      View in: PubMed
    75. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81. PMID: 25316813.
      View in: PubMed
    76. Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS, Kucherlapati R. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 Oct 28; 111(43):15544-9. PMID: 25313082.
      View in: PubMed
    77. Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, Zhang J, Seth S, Caulin C, Clayman GL, El-Naggar AK, Gibbs RA, Weber RS, Myers JN, Wheeler DA, Frederick MJ. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92. PMID: 25303977.
      View in: PubMed
    78. Ju YS, Alexandrov LB, Gerstung M, Martincorena I, Nik-Zainal S, Ramakrishna M, Davies HR, Papaemmanuil E, Gundem G, Shlien A, Bolli N, Behjati S, Tarpey PS, Nangalia J, Massie CE, Butler AP, Teague JW, Vassiliou GS, Green AR, Du MQ, Unnikrishnan A, Pimanda JE, Teh BT, Munshi N, Greaves M, Vyas P, El-Naggar AK, Santarius T, Collins VP, Grundy R, Taylor JA, Hayes DN, Malkin D, Foster CS, Warren AY, Whitaker HC, Brewer D, Eeles R, Cooper C, Neal D, Visakorpi T, Isaacs WB, Bova GS, Flanagan AM, Futreal PA, Lynch AG, Chinnery PF, McDermott U, Stratton MR, Campbell PJ. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. Elife. 2014 Oct 01; 3. PMID: 25271376.
      View in: PubMed
    79. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50. PMID: 25154822.
      View in: PubMed
    80. Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK. Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics. Head Neck. 2014 Nov; 36(11):1662-8. PMID: 24115154.
      View in: PubMed
    81. Li J, Perlaky L, Rao P, Weber RS, El-Naggar AK. Development and characterization of salivary adenoid cystic carcinoma cell line. Oral Oncol. 2014 Oct; 50(10):991-9. PMID: 25086988.
      View in: PubMed
    82. Xiong S, Tu H, Kollareddy M, Pant V, Li Q, Zhang Y, Jackson JG, Suh YA, Elizondo-Fraire AC, Yang P, Chau G, Tashakori M, Wasylishen AR, Ju Z, Solomon H, Rotter V, Liu B, El-Naggar AK, Donehower LA, Martinez LA, Lozano G. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):11145-50. PMID: 25024203.
      View in: PubMed
    83. Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014 Oct 20; 32(30):3365-73. PMID: 24958820.
      View in: PubMed
    84. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer. 2014 Oct 01; 120(19):3082-8. PMID: 24898672.
      View in: PubMed
    85. Pickering CR, Zhang J, Neskey DM, Zhao M, Jasser SA, Wang J, Ward A, Tsai CJ, Ortega Alves MV, Zhou JH, Drummond J, El-Naggar AK, Gibbs R, Weinstein JN, Wheeler DA, Wang J, Frederick MJ, Myers JN. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014 Jul 15; 20(14):3842-8. PMID: 24874835.
      View in: PubMed
    86. Li Q, Zhang Y, El-Naggar AK, Xiong S, Yang P, Jackson JG, Chau G, Lozano G. Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors. Mol Cancer Res. 2014 Jun; 12(6):901-11. PMID: 24598047.
      View in: PubMed
    87. Savar A, Acin S, Gonzalez CL, El-Sawy T, Mejia O, Li Z, Esmaeli B, Lacy-Hulbert A, El-Naggar AK, McCarty JH, Caulin C. Loss of epithelial p53 and av integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment. Oncogene. 2015 Jan 22; 34(4):516-24. PMID: 24469034.
      View in: PubMed
    88. Bell D, Holsinger FC, Ordonez N, El-Naggar AK. Intestinal-type adenocarcinoma of the larynx: Report of a rare aggressive phenotype and discussion of histogenesis. Head Neck. 2014 May; 36(5):E44-7. PMID: 24038722.
      View in: PubMed
    89. Neskey DM, Klein JD, Hicks S, Garden AS, Bell DM, El-Naggar AK, Kies MS, Weber RS, Kupferman ME. Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1195-202. PMID: 24076756.
      View in: PubMed
    90. Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity! Adv Anat Pathol. 2013 Nov; 20(6):416-23. PMID: 24113312.
      View in: PubMed
    91. Takahashi Y, Bell D, Agarwal G, Roberts D, Xie TX, El-Naggar A, Myers JN, Hanna EY. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1094-102. PMID: 23836481.
      View in: PubMed
    92. Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer. 2013 Dec; 20(6):809-23. PMID: 24127332.
      View in: PubMed
    93. Bell D, Hanna EY, Miele L, Roberts D, Weber RS, El-Naggar AK. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol. 2014 Feb; 18(1):10-3. PMID: 24238845.
      View in: PubMed
    94. Milbury K, Rosenthal DI, El-Naggar A, Badr H. An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancer. Oral Oncol. 2013 Nov; 49(11):1067-71. PMID: 23953777.
      View in: PubMed
    95. El-Naggar AK, Kaye FJ, Stenman G. The 3rd Salivary Gland Tumor Workshop meeting report. Head Neck. 2013 Aug; 35(8):1057-60. PMID: 23677839.
      View in: PubMed
    96. Millare GG, Guha-Thakurta N, Sturgis EM, El-Naggar AK, Debnam JM. Imaging findings of head and neck dermatofibrosarcoma protuberans. AJNR Am J Neuroradiol. 2014 Feb; 35(2):373-8. PMID: 23907249.
      View in: PubMed
    97. Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer. 2013 Aug; 20(4):603-10. PMID: 23766237.
      View in: PubMed
    98. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, El-Naggar AK. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778. PMID: 23825564.
      View in: PubMed
    99. Ow TJ, Hanna EY, Roberts DB, Levine NB, El-Naggar AK, Rosenthal DI, DeMonte F, Kupferman ME. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014 Apr; 36(4):524-30. PMID: 23780581.
      View in: PubMed
    100. Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman SM, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013 Jul; 123(7):2965-8. PMID: 23778141.
      View in: PubMed
    101. Perissinotti AJ, Lee Pierce M, Pace MB, El-Naggar A, Kies MS, Kupferman M. The role of trastuzumab in the management of salivary ductal carcinomas. Anticancer Res. 2013 Jun; 33(6):2587-91. PMID: 23749912.
      View in: PubMed
    102. Cockerill CC, Daram S, El-Naggar AK, Hanna EY, Weber RS, Kupferman ME. Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7. PMID: 23728801.
      View in: PubMed
    103. Gelbard A, Hale KS, Takahashi Y, Davies M, Kupferman ME, El-Naggar AK, Myers JN, Hanna EY. Molecular profiling of sinonasal undifferentiated carcinoma. Head Neck. 2014 Jan; 36(1):15-21. PMID: 23633104.
      View in: PubMed
    104. Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, Zweidler-McKay PA, Wu X, El-Naggar AK, Weinstein JN, Wang J, Muzny DM, Gibbs RA, Wheeler DA, Myers JN, Frederick MJ. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013 Jul; 3(7):770-81. PMID: 23619168.
      View in: PubMed
    105. Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman SM, El-Naggar AK. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57. PMID: 23583282.
      View in: PubMed
    106. Bell D, El-Naggar AK. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications. Head Neck Pathol. 2013 Mar; 7(1):23-7. PMID: 23459841.
      View in: PubMed
    107. Arduino PG, Bagan J, El-Naggar AK, Carrozzo M. Urban legends series: oral leukoplakia. Oral Dis. 2013 Oct; 19(7):642-59. PMID: 23379968.
      View in: PubMed
    108. Guan X, Sturgis EM, Song X, Liu Z, El-Naggar AK, Wei Q, Li G. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer Lett. 2013 Apr 28; 330(2):233-40. PMID: 23219900.
      View in: PubMed
    109. Gillenwater AM, Frank SJ, Fatani H, El-Naggar AK. Primary intestinal-like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype. Head Neck. 2013 Aug; 35(8):E234-6. PMID: 23108630.
      View in: PubMed
    110. Ivanov SV, Panaccione A, Brown B, Guo Y, Moskaluk CA, Wick MJ, Brown JL, Ivanova AV, Issaeva N, El-Naggar AK, Yarbrough WG. TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene. 2013 Aug 08; 32(32):3698-710. PMID: 23027130.
      View in: PubMed
    111. Sandulache VC, Ow TJ, Daram SP, Hamilton J, Skinner H, Bell D, Rosenthal DI, Beadle BM, Ang KK, Kies MS, Johnson FM, El-Naggar AK, Myers JN. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck. 2013 Oct; 35(10):1454-60. PMID: 23018868.
      View in: PubMed
    112. El-Naggar AK. Salivary gland cancer: assessing elusive behavior. Expert Rev Endocrinol Metab. 2012 Sep; 7(5):479-481. PMID: 30780890.
      View in: PubMed
    113. Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012 Jul; 22(3):245-53. PMID: 22687949.
      View in: PubMed
    114. Jackson JG, Pant V, Li Q, Chang LL, Quintás-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y, El-Naggar AK, Lozano G. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell. 2012 Jun 12; 21(6):793-806. PMID: 22698404.
      View in: PubMed
    115. Thariat J, Ang KK, Allen PK, Ahamad A, Williams MD, Myers JN, El-Naggar AK, Ginsberg LE, Rosenthal DI, Glisson BS, Morrison WH, Weber RS, Garden AS. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e367-74. PMID: 22284033.
      View in: PubMed
    116. Sano D, Gule MK, Rosenthal DI, Bell D, Yates J, El-Naggar AK, Myers JN. Early postoperative epidermal growth factor receptor inhibition: safety and effectiveness in inhibiting microscopic residual of oral squamous cell carcinoma in vivo. Head Neck. 2013 Mar; 35(3):321-8. PMID: 22367702.
      View in: PubMed
    117. Bell D, N Myers J, Rao PH, El-Naggar AK. t(3;8) as the sole chromosomal abnormality in a myoepithelial carcinoma ex pleomorphic adenoma: a putative progression event. Head Neck. 2013 Jun; 35(6):E181-3. PMID: 22287457.
      View in: PubMed
    118. Galer C, Santillan AA, Chelius D, Huh W, El-Naggar A, Hanna E, Weber RS, Kupferman ME. Minor salivary gland malignancies in the pediatric population. Head Neck. 2012 Nov; 34(11):1648-51. PMID: 22267165.
      View in: PubMed
    119. Lewis CM, Glisson BS, Feng L, Wan F, Tang X, Wistuba II, El-Naggar AK, Rosenthal DI, Chambers MS, Lustig RA, Weber RS. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Mar 01; 18(5):1435-46. PMID: 22261807.
      View in: PubMed
    120. Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jan; 16(1):103-19. PMID: 22239440.
      View in: PubMed
    121. Burch-Smith R, Ordonez NG, Ginsberg LE, Ater JL, El Naggar AK. Oral extragonadal yolk sac tumor in a patient with Aicardi syndrome: putative origin and differential diagnosis. Hum Pathol. 2012 Jun; 43(6):939-42. PMID: 22225777.
      View in: PubMed
    122. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, Weber RS, Kupferman ME. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012 Aug 15; 118(16):3928-36. PMID: 22180391.
      View in: PubMed
    123. Li N, Xu L, Zhao H, El-Naggar AK, Sturgis EM. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer. 2012 Aug 15; 118(16):3945-53. PMID: 22179977.
      View in: PubMed
    124. El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012 Apr; 34(4):459-61. PMID: 22180304.
      View in: PubMed
    125. Sen B, Peng S, Woods DM, Wistuba I, Bell D, El-Naggar AK, Lai SY, Johnson FM. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res. 2012 Jan 01; 18(1):127-39. PMID: 22090359.
      View in: PubMed
    126. Berinstein NL, Wolf GT, Naylor PH, Baltzer L, Egan JE, Brandwein HJ, Whiteside TL, Goldstein LC, El-Naggar A, Badoual C, Fridman WH, White JM, Hadden JW. Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. Cancer Immunol Immunother. 2012 Jun; 61(6):771-82. PMID: 22057678.
      View in: PubMed
    127. Bhayani MK, Yener M, El-Naggar A, Garden A, Hanna EY, Weber RS, Kupferman ME. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8. PMID: 22020577.
      View in: PubMed
    128. Kies MS, Boatright DH, Li G, Blumenschein G, El-Naggar AK, Brandon Gunn G, Lewin JS, Steinhaus GD, Sturgis EM. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults. Head Neck. 2012 Sep; 34(9):1255-62. PMID: 22009800.
      View in: PubMed
    129. Suh YA, Post SM, Elizondo-Fraire AC, Maccio DR, Jackson JG, El-Naggar AK, Van Pelt C, Terzian T, Lozano G. Multiple stress signals activate mutant p53 in vivo. Cancer Res. 2011 Dec 01; 71(23):7168-75. PMID: 21983037.
      View in: PubMed
    130. Shin DH, Min HY, El-Naggar AK, Lippman SM, Glisson B, Lee HY. Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48. PMID: 21980128.
      View in: PubMed
    131. Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14. PMID: 21976542.
      View in: PubMed
    132. Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011 Oct 01; 12(7):569-73. PMID: 21785271.
      View in: PubMed
    133. Acin S, Li Z, Mejia O, Roop DR, El-Naggar AK, Caulin C. Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. J Pathol. 2011 Dec; 225(4):479-89. PMID: 21952947.
      View in: PubMed
    134. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, Teague JW, Baxter EJ, Score J, Galli A, Della Porta MG, Travaglino E, Groves M, Tauro S, Munshi NC, Anderson KC, El-Naggar A, Fischer A, Mustonen V, Warren AJ, Cross NC, Green AR, Futreal PA, Stratton MR, Campbell PJ. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011 Oct 13; 365(15):1384-95. PMID: 21995386.
      View in: PubMed
    135. Jerjes WK, Upile T, Wong BJ, Betz CS, Sterenborg HJ, Witjes MJ, Berg K, van Veen R, Biel MA, El-Naggar AK, Mosse CA, Olivo M, Richards-Kortum R, Robinson DJ, Rosen J, Yodh AG, Kendall C, Ilgner JF, Amelink A, Bagnato V, Barr H, Bolotine L, Bigio I, Chen Z, Choo-Smith LP, D'Cruz AK, Gillenwater A, Leunig A, MacRobert AJ, McKenzie G, Sandison A, Soo KC, Stepp H, Stone N, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Hopper C. The future of medical diagnostics: review paper. Head Neck Oncol. 2011 Aug 23; 3:38. PMID: 21861912.
      View in: PubMed
    136. Bell D, Bell A, Roberts D, Weber RS, El-Naggar AK. Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma. Cancer. 2012 Mar 01; 118(5):1288-92. PMID: 21800291.
      View in: PubMed
    137. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011 Aug 26; 333(6046):1154-7. PMID: 21798897.
      View in: PubMed
    138. Xu L, Li G, Wei Q, El-Naggar AK, Sturgis EM. Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer. 2012 Mar 01; 118(5):1228-35. PMID: 21800288.
      View in: PubMed
    139. Likhacheva A, Rosenthal DI, Hanna E, Kupferman M, Demonte F, El-Naggar AK. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol. 2011 Jul 27; 3:32. PMID: 21794118.
      View in: PubMed
    140. Zevallos JP, Jain KS, Roberts D, El-Naggar A, Hanna EY, Kupferman ME. Sinonasal malignancies in children: a 10-year, single-institutional review. Laryngoscope. 2011 Sep; 121(9):2001-3. PMID: 21739433.
      View in: PubMed
    141. Gomez-Rivera F, El-Naggar AK, Guha-Thakurta N, Kupferman ME. Rheumatoid arthritis mimicking metastatic squamous cell carcinoma. Head Neck Oncol. 2011 May 14; 3:26. PMID: 21569598.
      View in: PubMed
    142. Mitani Y, Li J, Weber RS, Lippman SL, Flores ER, Caulin C, El-Naggar AK. Expression and regulation of the ?N and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings. Am J Pathol. 2011 Jul; 179(1):391-9. PMID: 21703418.
      View in: PubMed
    143. Williams MD, Zhang L, Elliott DD, Perrier ND, Lozano G, Clayman GL, El-Naggar AK. Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. Hum Pathol. 2011 Sep; 42(9):1213-20. PMID: 21420716.
      View in: PubMed
    144. Karpowicz MK, Shalmon B, Molberg KH, El-Naggar AK. Melanoma in a carcinoma ex pleomorphic adenoma of the parotid gland: a case report and putative histogenesis. Hum Pathol. 2011 Sep; 42(9):1355-8. PMID: 21411120.
      View in: PubMed
    145. Jiffar T, Yilmaz T, Lee J, Hanna E, El-Naggar A, Yu D, Myers JN, Kupferman ME. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma. Oncogene. 2011 Jul 14; 30(28):3163-73. PMID: 21383688.
      View in: PubMed
    146. Wang Y, Suh YA, Fuller MY, Jackson JG, Xiong S, Terzian T, Quintás-Cardama A, Bankson JA, El-Naggar AK, Lozano G. Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation. J Clin Invest. 2011 Mar; 121(3):893-904. PMID: 21285512.
      View in: PubMed
    147. Upile T, Jerjes WK, Sterenborg HJ, Wong BJ, El-Naggar AK, Ilgner JF, Sandison A, Witjes MJ, Biel MA, van Veen R, Hamdoon Z, Gillenwater A, Mosse CA, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Barr H, Chen Z, Berg K, D'Cruz AK, Sudhoff H, Stone N, Kendall C, Fisher S, MacRobert AJ, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Bigio I, Yodh AG, Hopper C. At the frontiers of surgery: review. Head Neck Oncol. 2011 Feb 09; 3(1):7. PMID: 21306627.
      View in: PubMed
    148. Hong DS, Cabanillas ME, Wheler J, Naing A, Tsimberidou AM, Ye L, Busaidy NL, Waguespack SG, Hernandez M, El Naggar AK, El Naggar AK, Bidyasar S, Wright J, Sherman SI, Kurzrock R. Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies. J Clin Endocrinol Metab. 2011 Apr; 96(4):997-1005. PMID: 21289252.
      View in: PubMed
    149. Frederick MJ, VanMeter AJ, Gadhikar MA, Henderson YC, Yao H, Pickering CC, Williams MD, El-Naggar AK, Sandulache V, Tarco E, Myers JN, Clayman GL, Liotta LA, Petricoin EF, Calvert VS, Fodale V, Wang J, Weber RS. Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. Am J Pathol. 2011 Feb; 178(2):548-71. PMID: 21281788.
      View in: PubMed
    150. Saintigny P, Zhang L, Fan YH, El-Naggar AK, Papadimitrakopoulou VA, Feng L, Lee JJ, Kim ES, Ki Hong W, Mao L. Gene expression profiling predicts the development of oral cancer. Cancer Prev Res (Phila). 2011 Feb; 4(2):218-29. PMID: 21292635.
      View in: PubMed
    151. Galer CE, Corey CL, Wang Z, Younes MN, Gomez-Rivera F, Jasser SA, Ludwig DL, El-Naggar AK, Weber RS, Myers JN. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma. Head Neck. 2011 Feb; 33(2):189-98. PMID: 20848439.
      View in: PubMed
    152. Devaney KO, Ferlito A, Rinaldo A, El-Naggar AK, Barnes L. Verrucous carcinoma (carcinoma cuniculatum) of the head and neck: what do we know now that we did not know a decade ago? Eur Arch Otorhinolaryngol. 2011 Apr; 268(4):477-80. PMID: 21286737.
      View in: PubMed
    153. Ryan JT, El-Naggar AK, Huh W, Hanna EY, Weber RS, Kupferman ME. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011 Dec; 33(12):1769-73. PMID: 21284057.
      View in: PubMed
    154. Bell A, Bell D, Weber RS, El-Naggar AK. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer. 2011 Jul 01; 117(13):2898-909. PMID: 21692051.
      View in: PubMed
    155. Sethi K, Sarkar S, Das S, Rajput S, Mazumder A, Roy B, Patra S, Mohanty B, El-Naggar AK, Mandal M. Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma. J Exp Ther Oncol. 2011; 9(3):187-99. PMID: 22070050.
      View in: PubMed
    156. Lewis CM, Hessel AC, Roberts DB, Guo YZ, Holsinger FC, Ginsberg LE, El-Naggar AK, Weber RS. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1205-11. PMID: 21173369.
      View in: PubMed
    157. Bell D, Holsinger CF, El-Naggar AK. CRTC1/MAML2 fusion transcript in central mucoepidermoid carcinoma of mandible--diagnostic and histogenetic implications. Ann Diagn Pathol. 2010 Dec; 14(6):396-401. PMID: 21074686.
      View in: PubMed
    158. Brooks HD, Glisson BS, Bekele BN, Johnson FM, Ginsberg LE, El-Naggar A, Culotta KS, Takebe N, Wright J, Tran HT, Papadimitrakopoulou VA. Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma. Cancer. 2011 May 15; 117(10):2112-9. PMID: 21523723.
      View in: PubMed
    159. Diegel CR, Cho KR, El-Naggar AK, Williams BO, Lindvall C. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma. Cancer Res. 2010 Nov 15; 70(22):9143-52. PMID: 21062985.
      View in: PubMed
    160. Roblyer D, Kurachi C, Stepanek V, Schwarz RA, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R. Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasia. J Biomed Opt. 2010 Nov-Dec; 15(6):066017. PMID: 21198191.
      View in: PubMed
    161. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, Wistuba I, Flores ER. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature. 2010 Oct 21; 467(7318):986-90. PMID: 20962848.
      View in: PubMed
    162. Liu Z, Liu D, Bojdani E, El-Naggar AK, Vasko V, Xing M. IQGAP1 plays an important role in the invasiveness of thyroid cancer. Clin Cancer Res. 2010 Dec 15; 16(24):6009-18. PMID: 20959410.
      View in: PubMed
    163. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM, Wei Q. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010 Oct 15; 116(20):4753-60. PMID: 20549817.
      View in: PubMed
    164. Niu J, Huang YJ, Wei S, Liu Z, Wang LE, Chang S, Chamberlain RM, El-Naggar AK, Sturgis EM, Wei Q. Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk. Head Neck. 2011 May; 33(5):650-60. PMID: 20949447.
      View in: PubMed
    165. Lo EJ, Bell D, Woo JS, Li G, Hanna EY, El-Naggar AK, Sturgis EM. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010 Oct; 120(10):1990-7. PMID: 20824783.
      View in: PubMed
    166. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010 Sep 21; 153(6):358-67. PMID: 20855800.
      View in: PubMed
    167. Bell D, Roberts D, Kies M, Rao P, Weber RS, El-Naggar AK. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer. 2010 Dec 15; 116(24):5749-56. PMID: 20824717.
      View in: PubMed
    168. Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31. PMID: 20702610.
      View in: PubMed
    169. Hessel AC, Moreno MA, Hanna EY, Roberts DB, Lewin JS, El-Naggar AK, Rosenthal DI, Weber RS. Compliance with quality assurance measures in patients treated for early oral tongue cancer. Cancer. 2010 Jul 15; 116(14):3408-16. PMID: 20564059.
      View in: PubMed
    170. Taoudi Benchekroun M, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, Lang W, Fan YH, Huang J, Feng L, Lee JJ, Kim ES, Hong WK, Johnson FM, Grandis JR, Mao L. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila). 2010 Jul; 3(7):800-9. PMID: 20570883.
      View in: PubMed
    171. Wei S, Liu Z, Zhao H, Niu J, Wang LE, El-Naggar AK, Sturgis EM, Wei Q. A single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck. Cancer. 2010 Jun 15; 116(12):2984-92. PMID: 20336794.
      View in: PubMed
    172. Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Cancer. 2010 Jun 15; 116(12):2974-83. PMID: 20564403.
      View in: PubMed
    173. Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Wistuba II, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman SM, Heymach JV. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. Mol Cancer Ther. 2010 Jun; 9(6):1755-63. PMID: 20530716.
      View in: PubMed
    174. Moskaluk CA, Frierson HF, El-Naggar AK, Futreal PA. C-kit gene mutations in adenoid cystic carcinoma are rare. Mod Pathol. 2010 Jun; 23(6):905-6; author reply 906-7. PMID: 20514080.
      View in: PubMed
    175. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M, Rosenthal DS, Hanna EY. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010 May 01; 116(9):2215-23. PMID: 20198705.
      View in: PubMed
    176. Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res. 2010 Apr 15; 16(8):2266-74. PMID: 20371674.
      View in: PubMed
    177. Bedard N, Pierce M, El-Nagger A, Anandasabapathy S, Gillenwater A, Richards-Kortum R. Emerging roles for multimodal optical imaging in early cancer detection: a global challenge. Technol Cancer Res Treat. 2010 Apr; 9(2):211-7. PMID: 20218743.
      View in: PubMed
    178. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1005-10. PMID: 20207504.
      View in: PubMed
    179. Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, Petruzelli G, Gourin CG, Wong RJ, Ferris RL, El Naggar A, Ridge JA, Paniello RC, Owzar K, McCall L, Chepeha DB, Yarbrough WG, Myers JN. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010 Mar 10; 28(8):1395-400. PMID: 20142602.
      View in: PubMed
    180. Li C, Lu J, Liu Z, Wang LE, Zhao H, El-Naggar AK, Sturgis EM, Wei Q. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila). 2010 Feb; 3(2):246-53. PMID: 20086182.
      View in: PubMed
    181. Kupferman ME, Jiffar T, El-Naggar A, Yilmaz T, Zhou G, Xie T, Feng L, Wang J, Holsinger FC, Yu D, Myers JN. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene. 2010 Apr 08; 29(14):2047-59. PMID: 20101235.
      View in: PubMed
    182. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman SM, Hong WK, Wei Q. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74. PMID: 20068090.
      View in: PubMed
    183. Lo EJ, Bell D, Woo J, Li G, Hanna EY, El-Naggar AK, Sturgis EM. Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010; 120 Suppl 4:S185. PMID: 21225783.
      View in: PubMed
    184. Anzick SL, Chen WD, Park Y, Meltzer P, Bell D, El-Naggar AK, Kaye FJ. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer. 2010 Jan; 49(1):59-69. PMID: 19827123.
      View in: PubMed
    185. Mithani SK, Shao C, Tan M, Smith IM, Califano JA, El-Naggar AK, Ha PK. Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands. PLoS One. 2009 Dec 30; 4(12):e8493. PMID: 20041111.
      View in: PubMed
    186. Nash JW, Hessel AC, Vigneswaran N, El-Naggar AK. Collagenous myofibroblastic tumor of the mandible: case report of a unique locally aggressive neoplasm. Head Neck Pathol. 2010 Mar; 4(1):44-8. PMID: 20237988.
      View in: PubMed
    187. El-Naggar AK, Kaye FJ, Shirazi Y, Gutkind JS, Forastiere AA. Meeting report--the NIDCR 2(nd) Salivary Gland Tumor Meeting, November 2008. Head Neck. 2009 Dec; 31(12):1542-3. PMID: 19890918.
      View in: PubMed
    188. Kies MS, Holsinger FC, Lee JJ, William WN, Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman SM, Hong WK, El-Naggar AK, Garden AS, Papadimitrakopoulou V. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 01; 28(1):8-14. PMID: 19917840.
      View in: PubMed
    189. Hong DS, Sebti SM, Newman RA, Blaskovich MA, Ye L, Gagel RF, Moulder S, Wheler JJ, Naing A, Tannir NM, Ng CS, Sherman SI, El Naggar AK, Khan R, Trent J, Wright JJ, Kurzrock R. Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res. 2009 Nov 15; 15(22):7061-8. PMID: 19903778.
      View in: PubMed
    190. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila). 2009 Nov; 2(11):931-41. PMID: 19892663.
      View in: PubMed
    191. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim ES, Hong WK, Lippman SM, Mao L. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res. 2009 Oct 01; 15(19):6284-91. PMID: 19773378.
      View in: PubMed
    192. Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma. Cancer Prev Res (Phila). 2009 Sep; 2(9):823-9. PMID: 19737986.
      View in: PubMed
    193. Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck. 2009 Sep; 31(9):1152-63. PMID: 19360746.
      View in: PubMed
    194. Bell D, Kupferman ME, Williams MD, Rashid A, El-Naggar AK. Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype. Hum Pathol. 2009 Dec; 40(12):1798-802. PMID: 19695679.
      View in: PubMed
    195. Lu J, Hu Z, Wei S, Wang LE, Liu Z, El-Naggar AK, Sturgis EM, Wei Q. A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis. 2009 Oct; 30(10):1717-21. PMID: 19625347.
      View in: PubMed
    196. Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, Biel MA, Bigio I, Wong BJ, Gillenwater A, MacRobert AJ, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Mosse CA, Barr H, Chen Z, Berg K, D'Cruz AK, Stone N, Kendall C, Fisher S, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Yodh AG, Hopper C. Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol. 2009 Jul 13; 1:25. PMID: 19594907.
      View in: PubMed
    197. Nitin N, Carlson AL, Muldoon T, El-Naggar AK, Gillenwater A, Richards-Kortum R. Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose. Int J Cancer. 2009 Jun 01; 124(11):2634-42. PMID: 19173294.
      View in: PubMed
    198. Nitin N, Rosbach KJ, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum RR. Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. Neoplasia. 2009 Jun; 11(6):542-51. PMID: 19484143.
      View in: PubMed
    199. Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med. 2009 May 26; 6(5):e1000068. PMID: 19536326.
      View in: PubMed
    200. Mazumdar A, Henderson YC, El-Naggar AK, Sen S, Clayman GL. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck. 2009 May; 31(5):625-34. PMID: 19107951.
      View in: PubMed
    201. Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, Ang KK, Story MD. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck. 2009 May; 31(5):642-54. PMID: 19260130.
      View in: PubMed
    202. Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila). 2009 May; 2(5):423-31. PMID: 19401530.
      View in: PubMed
    203. Schwarz RA, Gao W, Redden Weber C, Kurachi C, Lee JJ, El-Naggar AK, Richards-Kortum R, Gillenwater AM. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer. 2009 Apr 15; 115(8):1669-79. PMID: 19170229.
      View in: PubMed
    204. Holsinger FC, Kies MS, Diaz EM, Gillenwater AM, Lewin JS, Ginsberg LE, Glisson BS, Garden AS, Ark N, Lin HY, Lee JJ, El-Naggar AK, Ki Hong W, Shin DM, Khuri FR. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol. 2009 Apr 20; 27(12):1976-82. PMID: 19289628.
      View in: PubMed
    205. Batsakis JG, Ayala A, El Naggar AK. In memoriam: Mario A. Luna, MD. Adv Anat Pathol. 2009 Mar; 16(2):133-4. PMID: 19685607.
      View in: PubMed
    206. Santarpia L, Sherman SI, Marabotti A, Clayman GL, El-Naggar AK. Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma. Hum Pathol. 2009 Jun; 40(6):827-33. PMID: 19200582.
      View in: PubMed
    207. Chakravarty G, Santillan AA, Galer C, Adams HP, El-Naggar AK, Jasser SA, Mohsin S, Mondal D, Clayman GL, Myers JN. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer. Exp Biol Med (Maywood). 2009 Apr; 234(4):372-86. PMID: 19176870.
      View in: PubMed
    208. Henderson YC, Shellenberger TD, Williams MD, El-Naggar AK, Fredrick MJ, Cieply KM, Clayman GL. High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin Cancer Res. 2009 Jan 15; 15(2):485-91. PMID: 19147753.
      View in: PubMed
    209. Cordes B, Williams MD, Tirado Y, Bell D, Rosenthal DI, Al-Dhahri SF, Hanna EY, El-Naggar AK. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol. 2009 Mar; 40(3):283-92. PMID: 19150107.
      View in: PubMed
    210. El-Naggar AK, Hopper C, Upile T, Jerjes W. Head & Neck Oncology: purpose, scope and goals-charting the future. Head Neck Oncol. 2009 Jan 12; 1:1. PMID: 19284679.
      View in: PubMed
    211. Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman SM, Hittelman WN, Hong WK. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21. PMID: 19139013.
      View in: PubMed
    212. Gelbard A, Kupferman ME, Jasser SA, Chen W, El-Naggar AK, Myers JN, Hanna EY. An orthotopic murine model of sinonasal malignancy. Clin Cancer Res. 2008 Nov 15; 14(22):7348-57. PMID: 19010850.
      View in: PubMed
    213. Pavlova I, Weber CR, Schwarz RA, Williams M, El-Naggar A, Gillenwater A, Richards-Kortum R. Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer. J Biomed Opt. 2008 Nov-Dec; 13(6):064012. PMID: 19123659.
      View in: PubMed
    214. Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF. High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2008 Nov; 93(11):4367-72. PMID: 18765511.
      View in: PubMed
    215. Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, Zhao YJ, Li XN, Cai WW, El-Naggar AK, Baladandayuthapani V, Kittrell FS, Rao PH, Medina D, Pati D. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13033-8. PMID: 18728194.
      View in: PubMed
    216. Choi S, Sano D, Cheung M, Zhao M, Jasser SA, Ryan AJ, Mao L, Chen WT, El-Naggar AK, Myers JN. Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model. Clin Cancer Res. 2008 Aug 15; 14(16):5081-9. PMID: 18698025.
      View in: PubMed
    217. Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, El-Naggar AK. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008 Aug 15; 14(16):5181-7. PMID: 18698036.
      View in: PubMed
    218. Chen X, Sturgis EM, El-Naggar AK, Wei Q, Li G. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis. 2008 Nov; 29(11):2120-5. PMID: 18701437.
      View in: PubMed
    219. Santarpia L, El-Naggar AK, Sherman SI, Hymes SR, Gagel RF, Shaw S, Sarlis NJ. Four patients with cutaneous metastases from medullary thyroid cancer. Thyroid. 2008 Aug; 18(8):901-5. PMID: 18651821.
      View in: PubMed
    220. Chattopadhyay C, El-Naggar AK, Williams MD, Clayman GL. Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma. Head Neck. 2008 Aug; 30(8):991-1000. PMID: 18327775.
      View in: PubMed
    221. Chambers MS, Tomsett KL, Artopoulou II, Garden AS, El-Naggar AK, Martin JW, Keene HJ. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation. J Prosthet Dent. 2008 Aug; 100(2):142-6. PMID: 18672129.
      View in: PubMed
    222. Zhai X, Zhao H, Liu Z, Wang LE, El-Naggar AK, Sturgis EM, Wei Q. Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. Clin Cancer Res. 2008 Jul 01; 14(13):4345-52. PMID: 18594018.
      View in: PubMed
    223. Thariat J, Ahamad A, El-Naggar AK, Williams MD, Holsinger FC, Glisson BS, Allen PK, Morrison WH, Weber RS, Ang KK, Garden AS. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study. Cancer. 2008 Jun 15; 112(12):2698-709. PMID: 18429002.
      View in: PubMed
    224. Smith SL, Hessel AC, Luna MA, Malpica A, Rosenthal DI, El-Naggar AK. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch Otolaryngol Head Neck Surg. 2008 Jun; 134(6):592-5. PMID: 18559724.
      View in: PubMed
    225. Barboza JA, Iwakuma T, Terzian T, El-Naggar AK, Lozano G. Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol Cancer Res. 2008 Jun; 6(6):947-54. PMID: 18567799.
      View in: PubMed
    226. Liu Z, Hou P, Ji M, Guan H, Studeman K, Jensen K, Vasko V, El-Naggar AK, Xing M. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab. 2008 Aug; 93(8):3106-16. PMID: 18492751.
      View in: PubMed
    227. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res. 2008 May 01; 14(9):2664-72. PMID: 18451230.
      View in: PubMed
    228. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008 May 01; 112(9):2088-100. PMID: 18327819.
      View in: PubMed
    229. Yildirim G, Gillenwater AM, Ordonez NG, Garden AS, El-Naggar AK. Concurrent epithelioid malignant peripheral nerve sheath tumor and papillary thyroid carcinoma in the treated field of Hodgkin's disease. Head Neck. 2008 May; 30(5):675-9. PMID: 17972308.
      View in: PubMed
    230. Hong D, Ye L, Gagel R, Chintala L, El Naggar AK, Wright J, Kurzrock R. Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib. Mol Cancer Ther. 2008 May; 7(5):1001-6. PMID: 18445656.
      View in: PubMed
    231. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res. 2008 Apr 15; 14(8):2396-404. PMID: 18413830.
      View in: PubMed
    232. Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortum RR. In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol. 2008 Nov; 44(11):1059-66. PMID: 18396445.
      View in: PubMed
    233. Mishra A, El-Naggar AK, DeMonte F, Hanna EY. Endodermal sinus tumor of the paranasal sinuses. Head Neck. 2008 Apr; 30(4):539-43. PMID: 17902152.
      View in: PubMed
    234. Bell D, Luna MA, Weber RS, Kaye FJ, El-Naggar AK. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association. Genes Chromosomes Cancer. 2008 Apr; 47(4):309-14. PMID: 18181164.
      View in: PubMed
    235. Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res. 2008 Apr 01; 14(7):2095-101. PMID: 18381950.
      View in: PubMed
    236. Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, Gillenwater AM. Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt. 2008 Mar-Apr; 13(2):024019. PMID: 18465982.
      View in: PubMed
    237. Zhou G, Xie TX, Zhao M, Jasser SA, Younes MN, Sano D, Lin J, Kupferman ME, Santillan AA, Patel V, Gutkind JS, Ei-Naggar AK, Emberley ED, Watson PH, Matsuzawa SI, Reed JC, Myers JN. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene. 2008 Jun 05; 27(25):3527-38. PMID: 18223693.
      View in: PubMed
    238. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol. 2008 Jan 20; 26(3):354-60. PMID: 18202409.
      View in: PubMed
    239. Xiong P, Hu Z, Li C, Wang LE, El-Naggar AK, Sturgis EM, Wei Q. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2007 Dec 15; 121(12):2735-40. PMID: 17724733.
      View in: PubMed
    240. Lupinetti AD, Roberts DB, Williams MD, Kupferman ME, Rosenthal DI, Demonte F, El-Naggar A, Weber RS, Hanna EY. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31. PMID: 17960615.
      View in: PubMed
    241. Armistead PM, Salganick J, Roh JS, Steinert DM, Patel S, Munsell M, El-Naggar AK, Benjamin RS, Zhang W, Trent JC. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer. 2007 Nov 15; 110(10):2293-303. PMID: 17896786.
      View in: PubMed
    242. Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab. 2008 Jan; 93(1):278-84. PMID: 17989125.
      View in: PubMed
    243. Williams MD, Roberts D, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol. 2007 Nov; 31(11):1645-52. PMID: 18059220.
      View in: PubMed
    244. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9. PMID: 17975167.
      View in: PubMed
    245. El-Naggar AK. Pathobiology of head and neck squamous tumorigenesis. Curr Cancer Drug Targets. 2007 Nov; 7(7):606-12. PMID: 18045065.
      View in: PubMed
    246. Ohshiro K, Rayala SK, El-Naggar AK, Kumar R. Delivery of cytoplasmic proteins to autophagosomes. Autophagy. 2008 Jan; 4(1):104-6. PMID: 18000392.
      View in: PubMed
    247. Naqvi J, Ordonez NG, Luna MA, Williams MD, Weber RS, El-Naggar AK. Epithelioid hemangioendothelioma of the head and neck: role of podoplanin in the differential diagnosis. Head Neck Pathol. 2008 Mar; 2(1):25-30. PMID: 20614338.
      View in: PubMed
    248. Bell D, Zhao YJ, Rao PH, Weber RS, El-Naggar AK. Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue. Head Neck Pathol. 2007 Dec; 1(2):165-8. PMID: 20614269.
      View in: PubMed
    249. Elliott DD, Sherman SI, Busaidy NL, Williams MD, Santarpia L, Clayman GL, El-Naggar AK. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification. Hum Pathol. 2008 Jan; 39(1):15-20. PMID: 17949783.
      View in: PubMed
    250. Carlson AL, Gillenwater AM, Williams MD, El-Naggar AK, Richards-Kortum RR. Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia. Technol Cancer Res Treat. 2007 Oct; 6(5):361-74. PMID: 17877424.
      View in: PubMed
    251. Ohshiro K, Rayala SK, Kondo S, Gaur A, Vadlamudi RK, El-Naggar AK, Kumar R. Identifying the estrogen receptor coactivator PELP1 in autophagosomes. Cancer Res. 2007 Sep 01; 67(17):8164-71. PMID: 17804729.
      View in: PubMed
    252. Li C, Hu Z, Lu J, Liu Z, Wang LE, El-Naggar AK, Sturgis EM, Spitz MR, Wei Q. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007 Aug 15; 110(4):867-75. PMID: 17614107.
      View in: PubMed
    253. Chen K, Hu Z, Wang LE, Sturgis EM, El-Naggar AK, Zhang W, Wei Q. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2007 Sep; 28(9):2008-12. PMID: 17693666.
      View in: PubMed
    254. An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, El-Naggar AK, Spitz MR, Wei Q. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8. PMID: 17684138.
      View in: PubMed
    255. Valentin-Vega YA, Barboza JA, Chau GP, El-Naggar AK, Lozano G. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas. Hum Pathol. 2007 Oct; 38(10):1553-62. PMID: 17651783.
      View in: PubMed
    256. Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Clin Cancer Res. 2007 Jul 15; 13(14):4291-9. PMID: 17634559.
      View in: PubMed
    257. Chen K, Hu Z, Wang LE, Zhang W, El-Naggar AK, Sturgis EM, Wei Q. Polymorphic TP53BP1 and TP53 gene interactions associated with risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007 Jul 15; 13(14):4300-5. PMID: 17634560.
      View in: PubMed
    258. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer. 2007 Jul; 46(7):708-15. PMID: 17437281.
      View in: PubMed
    259. Li D, Wang LE, Chang P, El-Naggar AK, Sturgis EM, Wei Q. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Cancer Res. 2007 Jun 15; 67(12):5628-34. PMID: 17575128.
      View in: PubMed
    260. Koch JG, Gu X, Han Y, El-Naggar AK, Olson MV, Medina D, Jerry DJ, Blackburn AC, Peltz G, Amos CI, Lozano G. Mammary tumor modifiers in BALB/cJ mice heterozygous for p53. Mamm Genome. 2007 May; 18(5):300-9. PMID: 17557176.
      View in: PubMed
    261. Kim S, Yazici YD, Calzada G, Wang ZY, Younes MN, Jasser SA, El-Naggar AK, Myers JN. Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Mol Cancer Ther. 2007 Jun; 6(6):1785-92. PMID: 17575107.
      View in: PubMed
    262. Kaszuba SM, Zafereo ME, Rosenthal DI, El-Naggar AK, Weber RS. Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. Arch Otolaryngol Head Neck Surg. 2007 Jun; 133(6):546-50. PMID: 17576904.
      View in: PubMed
    263. Temam S, Kawaguchi H, El-Naggar AK, Jelinek J, Tang H, Liu DD, Lang W, Issa JP, Lee JJ, Mao L. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol. 2007 Jun 01; 25(16):2164-70. PMID: 17538160.
      View in: PubMed
    264. Zheng S, El-Naggar AK, Kim ES, Kurie JM, Lozano G. A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene. 2007 Oct 18; 26(48):6896-904. PMID: 17486075.
      View in: PubMed
    265. Schafer-Hales K, Iaconelli J, Snyder JP, Prussia A, Nettles JH, El-Naggar A, Khuri FR, Giannakakou P, Marcus AI. Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F function. Mol Cancer Ther. 2007 Apr; 6(4):1317-28. PMID: 17431110.
      View in: PubMed
    266. Ohshiro K, Rosenthal DI, Koomen JM, Streckfus CF, Chambers M, Kobayashi R, El-Naggar AK. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol. 2007 Mar; 30(3):743-9. PMID: 17273777.
      View in: PubMed
    267. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A. 2007 Feb 27; 104(9):3414-9. PMID: 17360660.
      View in: PubMed
    268. Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res. 2007 Feb 15; 13(4):1161-70. PMID: 17317825.
      View in: PubMed
    269. Younes MN, Yigitbasi OG, Yazici YD, Jasser SA, Bucana CD, El-Naggar AK, Mills GB, Myers JN. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):15-23. PMID: 17224516.
      View in: PubMed
    270. Williams MD, Chakravarti N, Kies MS, Maruya S, Myers JN, Haviland JC, Weber RS, Lotan R, El-Naggar AK. Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res. 2006 Dec 15; 12(24):7353-8. PMID: 17189407.
      View in: PubMed
    271. Barboza JA, Liu G, Ju Z, El-Naggar AK, Lozano G. p21 delays tumor onset by preservation of chromosomal stability. Proc Natl Acad Sci U S A. 2006 Dec 26; 103(52):19842-7. PMID: 17170138.
      View in: PubMed
    272. Younes MN, Park YW, Yazici YD, Gu M, Santillan AA, Nong X, Kim S, Jasser SA, El-Naggar AK, Myers JN. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol Cancer Ther. 2006 Nov; 5(11):2696-705. PMID: 17121916.
      View in: PubMed
    273. Williams MD, Hanna EY, El-Naggar AK. Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: restricted molecular abnormalities of certain genes to the malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul; 104(1):72-5. PMID: 17577546.
      View in: PubMed
    274. Ohshiro K, Rayala SK, Williams MD, Kumar R, El-Naggar AK. Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):5994-9. PMID: 17062671.
      View in: PubMed
    275. Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, Spitz MR, Wei Q. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602. PMID: 17000697.
      View in: PubMed
    276. Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res. 2006 Aug 15; 66(16):8210-8. PMID: 16912200.
      View in: PubMed
    277. Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Clin Cancer Res. 2006 Aug 01; 12(15):4755-65. PMID: 16899627.
      View in: PubMed
    278. Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, Mao L. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer. 2006 Aug 01; 107(3):563-9. PMID: 16804930.
      View in: PubMed
    279. Hsu ER, Gillenwater AM, Hasan MQ, Williams MD, El-Naggar AK, Richards-Kortum RR. Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent. Int J Cancer. 2006 Jun 15; 118(12):3062-71. PMID: 16395711.
      View in: PubMed
    280. Younes MN, Yazici YD, Kim S, Jasser SA, El-Naggar AK, Myers JN. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 1):3425-34. PMID: 16740767.
      View in: PubMed
    281. Lippman SM, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R. Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res. 2006 May 15; 12(10):3109-14. PMID: 16707609.
      View in: PubMed
    282. Nykter M, Hunt KK, Pollock RE, El-Naggar AK, Taylor E, Shmulevich I, Yli-Harja O, Zhang W. Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies. Technol Cancer Res Treat. 2006 Apr; 5(2):177-82. PMID: 16551137.
      View in: PubMed
    283. Yom SS, Rosenthal DI, El-Naggar AK, Kies MS, Hessel AC. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jun; 101(6):761-8. PMID: 16731397.
      View in: PubMed
    284. El-Naggar AK. Clear cell hidradenoma of the skin--a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion: Genes Chromosomes Cancer. 2005;43:202-205. Adv Anat Pathol. 2006 Mar; 13(2):80-2. PMID: 16670462.
      View in: PubMed
    285. Mandal M, Younes M, Swan EA, Jasser SA, Doan D, Yigitbasi O, McMurphey A, Ludwick J, El-Naggar AK, Bucana C, Mills GB, Myers JN. The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. Oral Oncol. 2006 Apr; 42(4):430-9. PMID: 16442835.
      View in: PubMed
    286. Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY. Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma. Clin Cancer Res. 2006 Jan 15; 12(2):653-61. PMID: 16428512.
      View in: PubMed
    287. Chakravarti N, El-Naggar AK, Lotan R, Anderson J, Diwan AH, Saadati HG, Diba R, Prieto VG, Esmaeli B. Expression of retinoid receptors in sebaceous cell carcinoma. J Cutan Pathol. 2006 Jan; 33(1):10-7. PMID: 16441406.
      View in: PubMed
    288. Vielh P, Carton M, Padoy E, de Rycke Y, Klijanienko J, El-Naggar AK, Asselain B. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. Cancer. 2005 Dec 25; 105(6):476-82. PMID: 16116603.
      View in: PubMed
    289. Massarelli E, Liu DD, Lee JJ, El-Naggar AK, Lo Muzio L, Staibano S, De Placido S, Myers JN, Papadimitrakopoulou VA. Akt activation correlates with adverse outcome in tongue cancer. Cancer. 2005 Dec 01; 104(11):2430-6. PMID: 16245318.
      View in: PubMed
    290. Simon C, Goepfert H, Rosenthal DI, Roberts D, El-Naggar A, Old M, Diaz EM, Myers JN. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006 Apr; 263(4):313-8. PMID: 16328403.
      View in: PubMed
    291. Giri U, Ashorn CL, Ramdas L, Stivers DN, Coombes K, El-Naggar AK, Ang KK, Story MD. Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation. Int J Radiat Oncol Biol Phys. 2006 Mar 01; 64(3):670-7. PMID: 16289374.
      View in: PubMed
    292. Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, Garden AS, Morrison WH, Rosenthal D, Weber RS, Chao KS. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys. 2006 Mar 01; 64(3):678-83. PMID: 16243444.
      View in: PubMed
    293. Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg. 2005 Oct; 131(10):874-8. PMID: 16230589.
      View in: PubMed
    294. Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, Hong WK, Lee HY. The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. Cancer Lett. 2006 Jul 28; 239(1):136-43. PMID: 16181731.
      View in: PubMed
    295. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005 Sep; 115(9):1561-7. PMID: 16148695.
      View in: PubMed
    296. Saffari B, Bernstein L, Hong DC, Sullivan-Halley J, Runnebaum IB, Grill HJ, Jones LA, El-Naggar A, Press MF. Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer. 2005 Sep-Oct; 15(5):952-63. PMID: 16174251.
      View in: PubMed
    297. Li J, El-Naggar A, Mao L. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer. 2005 Aug 15; 104(4):771-6. PMID: 15959912.
      View in: PubMed
    298. Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y, Schiff BA, El-Naggar A, Bekele BN, Mills GB, Myers JN. Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther. 2005 Aug; 4(8):1146-56. PMID: 16093430.
      View in: PubMed
    299. Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005 Aug; 28(4):385-92. PMID: 16062081.
      View in: PubMed
    300. Maruya S, Kies MS, Williams M, Myers JN, Weber RS, Batsakis JG, El-Naggar AK. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol. 2005 Jul; 36(7):821-7. PMID: 16084953.
      View in: PubMed
    301. Gillenwater A, Lewin J, Roberts D, El-Naggar A. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor. Laryngoscope. 2005 Jul; 115(7):1191-5. PMID: 15995505.
      View in: PubMed
    302. Chakravarti N, Saadati HG, El-Naggar AK, Lotan R, Diba RE, Esmaeli B. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid. Ophthalmic Plast Reconstr Surg. 2005 Jul; 21(4):292-7. PMID: 16052143.
      View in: PubMed
    303. Backous DD, DeMonte F, El-Naggar A, Wolf P, Weber RS. Craniofacial resection for nonmelanoma skin cancer of the head and neck. Laryngoscope. 2005 Jun; 115(6):931-7. PMID: 15933497.
      View in: PubMed
    304. Vadlamudi RK, Balasenthil S, Sahin AA, Kies M, Weber RS, Kumar R, El-Naggar AK. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum Pathol. 2005 Jun; 36(6):670-5. PMID: 16021574.
      View in: PubMed
    305. Mandal M, Kim S, Younes MN, Jasser SA, El-Naggar AK, Mills GB, Myers JN. The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer. 2005 May 23; 92(10):1899-905. PMID: 15870708.
      View in: PubMed
    306. Neumann AS, Lyons HJ, Shen H, Liu Z, Shi Q, Sturgis EM, Shete S, Spitz MR, El-Naggar A, Hong WK, Wei Q. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6. PMID: 15688408.
      View in: PubMed
    307. Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005 Sep; 20(9):1562-8. PMID: 16059628.
      View in: PubMed
    308. Marcus AI, Zhou J, O'Brate A, Hamel E, Wong J, Nivens M, El-Naggar A, Yao TP, Khuri FR, Giannakakou P. The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. Cancer Res. 2005 May 01; 65(9):3883-93. PMID: 15867388.
      View in: PubMed
    309. Maruya SI, Myers JN, Weber RS, Rosenthal DI, Lotan R, El-Naggar AK. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! Oral Oncol. 2005 Jul; 41(6):580-8. PMID: 15975520.
      View in: PubMed
    310. Massarelli E, Brown E, Tran NK, Liu DD, Izzo JG, Lee JJ, El-Naggar AK, Hong WK, Papadimitrakopoulou VA. Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis. Cancer. 2005 Mar 01; 103(5):952-9. PMID: 15666322.
      View in: PubMed
    311. Jayakumar A, Kang Y, Henderson Y, Mitsudo K, Liu X, Briggs K, Wang M, Frederick MJ, El-Naggar AK, Bebök Z, Clayman GL. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution. Arch Biochem Biophys. 2005 Mar 01; 435(1):89-102. PMID: 15680911.
      View in: PubMed
    312. Yom SS, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol. 2005 Mar; 18(3):315-9. PMID: 15492756.
      View in: PubMed
    313. Diaz EM, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL, DeMonte F. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005 Feb; 27(2):138-49. PMID: 15654688.
      View in: PubMed
    314. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005 Feb 01; 23(4):759-65. PMID: 15681519.
      View in: PubMed
    315. Baker H, Patel V, Molinolo AA, Shillitoe EJ, Ensley JF, Yoo GH, Meneses-García A, Myers JN, El-Naggar AK, Gutkind JS, Hancock WS. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol. 2005 Feb; 41(2):183-99. PMID: 15695121.
      View in: PubMed
    316. Cohn ML, Elliott DD, El-Naggar AK. Metastatic acinic cell carcinoma in a neurofibroma mistaken for carcinosarcoma. Head Neck. 2005 Jan; 27(1):76-80. PMID: 15565563.
      View in: PubMed
    317. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, El-Naggar AK, Lozano G. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell. 2004 Dec 17; 119(6):861-72. PMID: 15607981.
      View in: PubMed
    318. Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res. 2004 Dec 15; 10(24):8594-602. PMID: 15623643.
      View in: PubMed
    319. Rosenthal DI, Barker JL, El-Naggar AK, Glisson BS, Kies MS, Diaz EM, Clayman GL, Demonte F, Selek U, Morrison WH, Ang KK, Chao KS, Garden AS. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer. 2004 Dec 01; 101(11):2567-73. PMID: 15517582.
      View in: PubMed
    320. Shellenberger TD, Wang M, Gujrati M, Jayakumar A, Strieter RM, Burdick MD, Ioannides CG, Efferson CL, El-Naggar AK, Roberts D, Clayman GL, Frederick MJ. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 2004 Nov 15; 64(22):8262-70. PMID: 15548693.
      View in: PubMed
    321. Clark AL, Gillenwater A, Alizadeh-Naderi R, El-Naggar AK, Richards-Kortum R. Detection and diagnosis of oral neoplasia with an optical coherence microscope. J Biomed Opt. 2004 Nov-Dec; 9(6):1271-80. PMID: 15568948.
      View in: PubMed
    322. Curino A, Patel V, Nielsen BS, Iskander AJ, Ensley JF, Yoo GH, Holsinger FC, Myers JN, El-Nagaar A, Kellman RM, Shillitoe EJ, Molinolo AA, Gutkind JS, Bugge TH. Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography. Oral Oncol. 2004 Nov; 40(10):1026-32. PMID: 15509494.
      View in: PubMed
    323. Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, El-Naggar AK, Hong WK, Mao L, Oh YW. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int J Oncol. 2004 Oct; 25(4):993-9. PMID: 15375549.
      View in: PubMed
    324. Choi HR, Roberts DB, Johnigan RH, Sturgis EM, Rosenthal DI, Weber RS, Luna MA, Batsakis JG, El-Naggar AK. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol. 2004 Oct; 28(10):1299-310. PMID: 15371945.
      View in: PubMed
    325. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res. 2004 Oct 01; 10(19):6586-97. PMID: 15475448.
      View in: PubMed
    326. Tai SK, Lee JI, Ang KK, El-Naggar AK, Hassan KA, Liu D, Lee JJ, Ren H, Hong WK, Mao L. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication. Clin Cancer Res. 2004 Aug 15; 10(16):5554-7. PMID: 15328196.
      View in: PubMed
    327. Cohn ML, Callender DL, El-Naggar AK. Sebaceous carcinoma ex-pleomorphic adenoma: a rare phenotypic occurrence. Ann Diagn Pathol. 2004 Aug; 8(4):224-6. PMID: 15290674.
      View in: PubMed
    328. Barkan GA, El-Naggar AK. Primary synovial sarcoma of the parotid gland. Ann Diagn Pathol. 2004 Aug; 8(4):233-6. PMID: 15290676.
      View in: PubMed
    329. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26. PMID: 15287039.
      View in: PubMed
    330. Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004 Aug; 89(8):4142-5. PMID: 15292360.
      View in: PubMed
    331. Maruya S, Kim HW, Weber RS, Lee JJ, Kies M, Luna MA, Batsakis JG, El-Naggar AK. Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance. J Mol Diagn. 2004 Aug; 6(3):180-90. PMID: 15269293.
      View in: PubMed
    332. Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2004 Jul; 89(7):3521-6. PMID: 15240641.
      View in: PubMed
    333. Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):743-51. PMID: 15183477.
      View in: PubMed
    334. Li G, Sturgis EM, Wang LE, Chamberlain RM, Spitz MR, El-Naggar AK, Hong WK, Wei Q. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002. PMID: 15217930.
      View in: PubMed
    335. Li G, Sturgis EM, Wang LE, Chamberlain RM, Amos CI, Spitz MR, El-Naggar AK, Hong WK, Wei Q. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6. PMID: 15180941.
      View in: PubMed
    336. Zhang Z, Shi Q, Wang LE, Sturgis EM, Spitz MR, El-Naggar AK, Hong WK, Wei Q. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1081-3. PMID: 15184269.
      View in: PubMed
    337. Maruya S, Issa JP, Weber RS, Rosenthal DI, Haviland JC, Lotan R, El-Naggar AK. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res. 2004 Jun 01; 10(11):3825-30. PMID: 15173091.
      View in: PubMed
    338. Fung KM, Diaz EM, El-Naggar AK, Luna MA. Malignant rhabdoid tumor arising from a pleomorphic adenoma. Ann Diagn Pathol. 2004 Jun; 8(3):156-61. PMID: 15185263.
      View in: PubMed
    339. Jayakumar A, Kang Y, Mitsudo K, Henderson Y, Frederick MJ, Wang M, El-Naggar AK, Marx UC, Briggs K, Clayman GL. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A. Protein Expr Purif. 2004 May; 35(1):93-101. PMID: 15039071.
      View in: PubMed
    340. Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol. 2004 04; 19(2):565-74. PMID: 15024716.
      View in: PubMed
    341. Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 01; 350(14):1405-13. PMID: 15070790.
      View in: PubMed
    342. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004 Mar 01; 100(5):900-5. PMID: 14983483.
      View in: PubMed
    343. Svistun E, Alizadeh-Naderi R, El-Naggar A, Jacob R, Gillenwater A, Richards-Kortum R. Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence. Head Neck. 2004 Mar; 26(3):205-15. PMID: 14999795.
      View in: PubMed
    344. Hsu ER, Anslyn EV, Dharmawardhane S, Alizadeh-Naderi R, Aaron JS, Sokolov KV, El-Naggar AK, Gillenwater AM, Richards-Kortum RR. A far-red fluorescent contrast agent to image epidermal growth factor receptor expression. Photochem Photobiol. 2004 Mar; 79(3):272-9. PMID: 15115300.
      View in: PubMed
    345. Glisson B, Colevas AD, Haddad R, Krane J, El-Naggar A, Kies M, Costello R, Summey C, Arquette M, Langer C, Amrein PC, Posner M. HER2 expression in salivary gland carcinomas: dependence on histological subtype. Clin Cancer Res. 2004 Feb 01; 10(3):944-6. PMID: 14871971.
      View in: PubMed
    346. Yang Z, Bagheri-Yarmand R, Wang RA, Adam L, Papadimitrakopoulou VV, Clayman GL, El-Naggar A, Lotan R, Barnes CJ, Hong WK, Kumar R. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells. Clin Cancer Res. 2004 Jan 15; 10(2):658-67. PMID: 14760089.
      View in: PubMed
    347. Moran CA, Suster S, El-Naggar A, Luna MA. Carcinomas arising in multilocular thymic cysts of the neck: a clinicopathological study of three cases. Histopathology. 2004 Jan; 44(1):64-8. PMID: 14717671.
      View in: PubMed
    348. Esmaeli B, Ahmadi MA, Youssef A, Diba R, Amato M, Myers JN, Kies M, El-Naggar A. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 2004 Jan; 20(1):22-6. PMID: 14752305.
      View in: PubMed
    349. El-Naggar AK. Concurrent flow cytometric analysis of DNA and RNA. Methods Mol Biol. 2004; 263:371-84. PMID: 14976378.
      View in: PubMed
    350. El-Naggar AK, Vielh P. Solid tumor DNA content analysis. Methods Mol Biol. 2004; 263:355-70. PMID: 14976377.
      View in: PubMed
    351. Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK, Multani A, Chang S, Lozano G. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet. 2004 Jan; 36(1):63-8. PMID: 14702042.
      View in: PubMed
    352. Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK, Dent SY. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene. 2003 Dec 04; 22(55):8902-11. PMID: 14654786.
      View in: PubMed
    353. Barker JL, Glisson BS, Garden AS, El-Naggar AK, Morrison WH, Ang KK, Chao KS, Clayman G, Rosenthal DI. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer. 2003 Dec 01; 98(11):2322-8. PMID: 14635065.
      View in: PubMed
    354. Rudin CM, Cohen EE, Papadimitrakopoulou VA, Silverman S, Recant W, El-Naggar AK, Stenson K, Lippman SM, Hong WK, Vokes EE. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol. 2003 Dec 15; 21(24):4546-52. PMID: 14597742.
      View in: PubMed
    355. Choi HR, Sturgis EM, Rashid A, DeMonte F, Luna MA, Batsakis JG, El-Naggar AK. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol. 2003 Nov; 34(11):1101-7. PMID: 14652810.
      View in: PubMed
    356. Clark AL, Gillenwater AM, Collier TG, Alizadeh-Naderi R, El-Naggar AK, Richards-Kortum RR. Confocal microscopy for real-time detection of oral cavity neoplasia. Clin Cancer Res. 2003 Oct 15; 9(13):4714-21. PMID: 14581341.
      View in: PubMed
    357. Caudell JJ, Ballo MT, Zagars GK, Lewis VO, Weber KL, Lin PP, Marco RA, El-Naggar AK, Benjamin RS, Yasko AW. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):158-65. PMID: 12909228.
      View in: PubMed
    358. Choi HR, Sturgis EM, Rosenthal DI, Luna MA, Batsakis JG, El-Naggar AK. Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol. 2003 Sep; 27(9):1216-20. PMID: 12960805.
      View in: PubMed
    359. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer. 2003 Aug 01; 98(3):508-15. PMID: 12879467.
      View in: PubMed
    360. Dahlstrom KR, Adler-Storthz K, Etzel CJ, Liu Z, Dillon L, El-Naggar AK, Spitz MR, Schiller JT, Wei Q, Sturgis EM. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6. PMID: 12855639.
      View in: PubMed
    361. MacGregor AR, Batsakis JG, El-Naggar AK. Myofibroblastoma of the larynx: a study of two cases. Head Neck. 2003 Jul; 25(7):606-11. PMID: 12808665.
      View in: PubMed
    362. Biddle DA, Evans HL, Kemp BL, El-Naggar AK, Harvell JD, White WL, Iskandar SS, Prieto VG. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol. 2003 May; 27(5):673-81. PMID: 12717252.
      View in: PubMed
    363. Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. Biochemistry. 2003 Apr 08; 42(13):3874-81. PMID: 12667078.
      View in: PubMed
    364. Sabloff B, Munden RF, Melhem AI, El-Naggar AK, Putnam JB. Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. AJR Am J Roentgenol. 2003 Apr; 180(4):972. PMID: 12646438.
      View in: PubMed
    365. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 2003 Mar 15; 97(6):1464-70. PMID: 12627511.
      View in: PubMed
    366. Izzo JG, Papadimitrakopoulou VA, Liu DD, den Hollander PL, Babenko IM, Keck J, El-Naggar AK, Shin DM, Lee JJ, Hong WK, Hittelman WN. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst. 2003 Feb 05; 95(3):198-205. PMID: 12569141.
      View in: PubMed
    367. Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol. 2003 Feb; 22(2):409-14. PMID: 12527941.
      View in: PubMed
    368. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet. 2003 Feb; 33(2):208-13. PMID: 12539049.
      View in: PubMed
    369. Jayakumar A, Kang Y, Frederick MJ, Pak SC, Henderson Y, Holton PR, Mitsudo K, Silverman GA, EL-Naggar AK, Brömme D, Clayman GL. Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Arch Biochem Biophys. 2003 Jan 15; 409(2):367-74. PMID: 12504904.
      View in: PubMed
    370. Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 2003 Jan; 9(1):228-34. PMID: 12538474.
      View in: PubMed
    371. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res. 2003 Jan; 9(1):93-101. PMID: 12538456.
      View in: PubMed
    372. Papadimitrakopoulou VA, Liu DD, Mao L, Shin DM, El-Naggar A, Ibarguen H, Lee JJ, Hong WK, Hittelman WN. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions. Cancer Epidemiol Biomarkers Prev. 2002 Dec; 11(12):1605-10. PMID: 12496051.
      View in: PubMed
    373. Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY, Gong K. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Clin Cancer Res. 2002 Dec; 8(12):3796-802. PMID: 12473592.
      View in: PubMed
    374. El-Naggar AK, Kim HW, Clayman GL, Coombes MM, Le B, Lai S, Zhan F, Luna MA, Hong WK, Lee JJ. Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene. 2002 Nov 21; 21(53):8206-19. PMID: 12444558.
      View in: PubMed
    375. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK, Mao L. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res. 2002 Nov 15; 62(22):6414-7. PMID: 12438226.
      View in: PubMed
    376. Frierson HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 2002 Oct; 161(4):1315-23. PMID: 12368205.
      View in: PubMed
    377. Berrak SG, Ozek MM, Canpolat C, Dagçinar A, Sav A, El-Naggar A, Langford LA. Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors. Childs Nerv Syst. 2002 Oct; 18(9-10):485-91. PMID: 12382173.
      View in: PubMed
    378. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS, Benjamin RS. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002 Jul 15; 95(2):377-88. PMID: 12124838.
      View in: PubMed
    379. Sweeney P, El-Naggar AK, Lin SH, Pisters LL. Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol. 2002 Jul; 168(1):51-5. PMID: 12050491.
      View in: PubMed
    380. Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman SM. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res. 2002 Jul; 8(7):2067-72. PMID: 12114405.
      View in: PubMed
    381. Choi HR, Batsakis JG, Callender DL, Prieto VG, Luna MA, El-Naggar AK. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma? Am J Surg Pathol. 2002 Jun; 26(6):778-83. PMID: 12023583.
      View in: PubMed
    382. El-Naggar AK. Methods in molecular surgical pathology. Semin Diagn Pathol. 2002 May; 19(2):56-71. PMID: 12036282.
      View in: PubMed
    383. Batsakis JG, Medeiros JL, Luna MA, El-Naggar AK. Plasma cell dyscrasias and the head and neck. Ann Diagn Pathol. 2002 Apr; 6(2):129-40. PMID: 12004363.
      View in: PubMed
    384. Shmulevich I, Hunt K, El-Naggar A, Taylor E, Ramdas L, Labordé P, Hess KR, Pollock R, Zhang W. Tumor specific gene expression profiles in human leiomyosarcoma: an evaluation of intratumor heterogeneity. Cancer. 2002 Apr 01; 94(7):2069-75. PMID: 11932911.
      View in: PubMed
    385. Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. Cancer Res. 2002 Apr 01; 62(7):1952-5. PMID: 11929809.
      View in: PubMed
    386. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol. 2002 Feb; 33(2):158-64. PMID: 11957139.
      View in: PubMed
    387. Lee JI, Soria JC, Hassan KA, El-Naggar AK, Tang X, Liu DD, Hong WK, Mao L. Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg. 2001 Dec; 127(12):1441-5. PMID: 11735811.
      View in: PubMed
    388. Tseng JE, Glisson BS, Khuri FR, Shin DM, Myers JN, El-Naggar AK, Roach JS, Ginsberg LE, Thall PF, Wang X, Teddy S, Lawhorn KN, Zentgraf RE, Steinhaus GD, Pluda JM, Abbruzzese JL, Hong WK, Herbst RS. Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer. 2001 Nov 01; 92(9):2364-73. PMID: 11745292.
      View in: PubMed
    389. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001 Nov; 3(4):164-70. PMID: 11687600.
      View in: PubMed
    390. Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res. 2001 Oct; 7(10):2984-97. PMID: 11595686.
      View in: PubMed
    391. Papadimitrakopoulou VA, Izzo J, Mao L, Keck J, Hamilton D, Shin DM, El-Naggar A, den Hollander P, Liu D, Hittelman WN, Hong WK. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Clin Cancer Res. 2001 Oct; 7(10):3127-34. PMID: 11595705.
      View in: PubMed
    392. Hoang MP, Callender DL, Sola Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol. 2001 Oct; 19(4):865-71. PMID: 11562768.
      View in: PubMed
    393. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res. 2001 Aug; 7(8):2458-62. PMID: 11489826.
      View in: PubMed
    394. Jiang W, Ananthaswamy HN, Muller HK, Ouhtit A, Bolshakov S, Ullrich SE, El-Naggar AK, Kripke ML. UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9790-5. PMID: 11481437.
      View in: PubMed
    395. Evans SC, Viswanathan M, Grier JD, Narayana M, El-Naggar AK, Lozano G. An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2. Oncogene. 2001 Jul 05; 20(30):4041-9. PMID: 11494132.
      View in: PubMed
    396. Maciorowski Z, Klijanienko J, Padoy E, Mosseri V, Fourquet A, Chevillard S, El-Naggar AK, Vielh P. Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinoma. Cytometry. 2001 Jun 15; 46(3):150-6. PMID: 11449405.
      View in: PubMed
    397. El-Naggar AK, Lai S, Clayman GL, Mims B, Lippman SM, Coombes M, Luna MA, Lozano G. p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas. Carcinogenesis. 2001 May; 22(5):729-35. PMID: 11323391.
      View in: PubMed
    398. Spring PM, Myers JN, El-Naggar AK, Langstein HN. Malignant melanoma arising within a burn scar case report and review of the literature. Ann Otol Rhinol Laryngol. 2001 Apr; 110(4):369-76. PMID: 11307915.
      View in: PubMed
    399. Kim J, Shin DM, El-Naggar A, Lee JS, Corrales C, Lippman SM, Hong WK, Hittelman WN. Chromosome polysomy and histological characteristics in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):319-25. PMID: 11319171.
      View in: PubMed
    400. Pachmann K, Zhao S, Schenk T, Kantarjian H, El-Naggar AK, Siciliano MJ, Guo JQ, Arlinghaus RB, Andreeff M. Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification. Br J Haematol. 2001 Mar; 112(3):749-59. PMID: 11260080.
      View in: PubMed
    401. Klijanienko J, Lagacé R, Servois V, Lussier C, El-Naggar AK, Vielh P. Fine-needle sampling of primary neuroendocrine carcinomas of salivary glands: cytohistological correlations and clinical analysis. Diagn Cytopathol. 2001 Mar; 24(3):163-6. PMID: 11241898.
      View in: PubMed
    402. Slaton JW, Inoue K, Perrotte P, El-Naggar AK, Swanson DA, Fidler IJ, Dinney CP. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol. 2001 Feb; 158(2):735-43. PMID: 11159211.
      View in: PubMed
    403. Lee JI, Soria JC, Hassan K, Liu D, Tang X, El-Naggar A, Hong WK, Mao L. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res. 2001 Feb 01; 61(3):837-41. PMID: 11221865.
      View in: PubMed
    404. Barnett CC, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE. Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery. 2000 Dec; 128(6):973-82;discussion 982-3. PMID: 11114632.
      View in: PubMed
    405. Sheikh B, Nakahara I, El-Naggar A, Nagata I, Kikuchi H. A grading system for intracranial arteriovenous malformations applicable to endovascular procedures. Interv Neuroradiol. 2000 Nov 30; 6 Suppl 1:139-42. PMID: 20667236.
      View in: PubMed
    406. Maciorowski Z, Klijanienko J, Padoy E, Mosseri V, Diéras V, El-Naggar AK, Chevillard S, Vielh P. Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas. Cytometry. 2000 Oct 15; 42(5):264-9. PMID: 11025483.
      View in: PubMed
    407. Williamson JD, Simmons BH, el-Naggar A, Medeiros LJ. Mucoepidermoid carcinoma involving Warthin tumor. A report of five cases and review of the literature. Am J Clin Pathol. 2000 Oct; 114(4):564-70. PMID: 11026102.
      View in: PubMed
    408. Dano L, Guilly MN, Muleris M, Morlier JP, Altmeyer S, Vielh P, El-Naggar AK, Monchaux G, Dutrillaux B, Chevillard S. CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer. 2000 Sep; 29(1):1-8. PMID: 10918387.
      View in: PubMed
    409. Clifford JL, Menter DG, Yang X, Walch E, Zou C, Clayman GL, Schaefer TS, El-Naggar AK, Lotan R, Lippman SM. Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2000 Sep; 9(9):993-7. PMID: 11008921.
      View in: PubMed
    410. Audebert M, Chevillard S, Levalois C, Gyapay G, Vieillefond A, Klijanienko J, Vielh P, El Naggar AK, Oudard S, Boiteux S, Radicella JP. Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res. 2000 Sep 01; 60(17):4740-4. PMID: 10987279.
      View in: PubMed
    411. Lai S, Goepfert H, Gillenwater AM, Luna MA, El-Naggar AK. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma. Clin Cancer Res. 2000 Aug; 6(8):3172-6. PMID: 10955800.
      View in: PubMed
    412. Xu XC, Sola Gallego JJ, Lotan R, El-Naggar AK. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int J Oncol. 2000 Aug; 17(2):271-6. PMID: 10891535.
      View in: PubMed
    413. Tae K, El-Naggar AK, Yoo E, Feng L, Lee JJ, Hong WK, Hittelman WN, Shin DM. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res. 2000 Jul; 6(7):2821-8. PMID: 10914730.
      View in: PubMed
    414. Suarez PA, Adler-Storthz K, Luna MA, El-Naggar AK, Abdul-Karim FW, Batsakis JG. Papillary squamous cell carcinomas of the upper aerodigestive tract: a clinicopathologic and molecular study. Head Neck. 2000 Jul; 22(4):360-8. PMID: 10862019.
      View in: PubMed
    415. Frederick MJ, Henderson Y, Xu X, Deavers MT, Sahin AA, Wu H, Lewis DE, El-Naggar AK, Clayman GL. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol. 2000 Jun; 156(6):1937-50. PMID: 10854217.
      View in: PubMed
    416. Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng Sj, El-Naggar A, Hung MC. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000 May 11; 19(20):2398-403. PMID: 10828881.
      View in: PubMed
    417. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000 May; 6(5):1702-10. PMID: 10815888.
      View in: PubMed
    418. Sheikh B, Ohata K, El-Naggar A, Baba M, Hong B, Hakuba A. Contralateral approach to junctional C2-C3 and proximal C4 aneurysms of the internal carotid artery: microsurgical anatomic study. Neurosurgery. 2000 May; 46(5):1156-60; discussion 1160-1. PMID: 10807248.
      View in: PubMed
    419. Liu G, McDonnell TJ, Montes de Oca Luna R, Kapoor M, Mims B, El-Naggar AK, Lozano G. High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4174-9. PMID: 10760284.
      View in: PubMed
    420. Yen N, Ioannides CG, Xu K, Swisher SG, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano RJ, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Mukhopadhyay T, Nesbitt JC, Nguyen D, Perez-Soler R, Pisters KM, Putnam JB, Schrump DS, Shin DM, Walsh GL, Roth JA. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther. 2000 Apr; 7(4):530-6. PMID: 10811470.
      View in: PubMed
    421. Sorensen DM, Gokden M, El-Naggar A, Byers RM. Quiz case 1. Periosteal osteosarcoma (PO) of the mandible. Arch Otolaryngol Head Neck Surg. 2000 Apr; 126(4):550, 552. PMID: 10772315.
      View in: PubMed
    422. Milas M, Yu D, Lang A, Ge T, Feig B, El-Naggar AK, Pollock RE. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Cancer Gene Ther. 2000 Mar; 7(3):422-9. PMID: 10766348.
      View in: PubMed
    423. El-Naggar AK, Callender D, Coombes MM, Hurr K, Luna MA, Batsakis JG. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer. 2000 Feb; 27(2):162-8. PMID: 10612804.
      View in: PubMed
    424. Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, Shin HJ, Lee JJ, Lee JS, Gillenwater A, Myers J, Lippman SM, Hittelman WN, Hong WK. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J Natl Cancer Inst. 2000 Jan 05; 92(1):69-73. PMID: 10620636.
      View in: PubMed
    425. Klijanienko J, Vielh P, Batsakis JD, el-Naggar AK, Jelen M, Piekarski JD. Salivary gland tumours. Monogr Clin Cytol. 2000; 15:III-XII, 1-138. PMID: 10879373.
      View in: PubMed
    426. Sheikh B, Ohata K, El-Naggar A, Hong B, Tsuyuguchi N, Hakuba A. Contralateral approach to carotid cave aneurysms. Acta Neurochir (Wien). 2000; 142(1):33-7. PMID: 10664373.
      View in: PubMed
    427. Amin MB, de Peralta-Venturina MN, Ro JY, El-Naggar A, Mackay B, Ordonez N, Mani A, Ayala A. Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis. Am J Surg Pathol. 1999 Dec; 23(12):1455-63. PMID: 10584698.
      View in: PubMed
    428. el-Naggar AK, Lai S, Tucker SA, Clayman GL, Goepfert H, Hong WK, Huff V. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene. 1999 Nov 25; 18(50):7063-9. PMID: 10597307.
      View in: PubMed
    429. Brunnemann RB, Ro JY, Ordonez NG, Mooney J, El-Naggar AK, Ayala AG. Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol. 1999 Nov; 12(11):1034-42. PMID: 10574600.
      View in: PubMed
    430. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R, Xu XC. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. Am J Pathol. 1999 Nov; 155(5):1519-23. PMID: 10550308.
      View in: PubMed
    431. el-Naggar AK. Diagnostic molecular pathology comes of age. Adv Anat Pathol. 1999 Nov; 6(6):324-6. PMID: 10562894.
      View in: PubMed
    432. Klijanienko J, Couturier J, Galut M, El-Naggar AK, Maciorowski Z, Padoy E, Mosseri V, Vielh P. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples. Cancer. 1999 Oct 25; 87(5):312-8. PMID: 10536358.
      View in: PubMed
    433. El-Naggar AK, Dinh M, Tucker SL, Swanson D, Steck K, Vielh P. Numerical chromosomal changes in DNA hypodiploid solid tumors: restricted loss and gain of certain chromosomes. Cytometry. 1999 Oct 01; 37(2):107-12. PMID: 10486522.
      View in: PubMed
    434. Papadimitrakopoulou VA, Clayman GL, Shin DM, Myers JN, Gillenwater AM, Goepfert H, El-Naggar AK, Lewin JS, Lippman SM, Hong WK. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1999 Oct; 125(10):1083-9. PMID: 10522499.
      View in: PubMed
    435. El-Naggar AK, Lai S, Clayman GL, Zhou JH, Tucker SA, Myers J, Luna MA, Benedict WF. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol. 1999 Sep; 30(9):1013-8. PMID: 10492034.
      View in: PubMed
    436. Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Desjardins L, Schlienger P, Validire P, Vielh P. Histologically similar, synchronous or metachronous, lacrimal salivary-type and parotid gland tumors: A series of 11 cases. Head Neck. 1999 Sep; 21(6):512-6. PMID: 10449666.
      View in: PubMed
    437. Klijanienko J, El-Naggar AK, Vielh P. Fine-needle sampling findings in 26 carcinoma ex pleomorphic adenomas: diagnostic pitfalls and clinical considerations. Diagn Cytopathol. 1999 Sep; 21(3):163-6. PMID: 10450099.
      View in: PubMed
    438. el-Naggar AK, Lovell M, Callender DL, Ordonez NG, Killary AM. Cytogenetic analysis of a primary salivary gland myoepithelioma. Cancer Genet Cytogenet. 1999 Aug; 113(1):49-53. PMID: 10459346.
      View in: PubMed
    439. Batsakis JG, el-Naggar AK. Myoepithelium in salivary and mammary neoplasms is host-friendly. Adv Anat Pathol. 1999 Jul; 6(4):218-26. PMID: 10410175.
      View in: PubMed
    440. Ohata K, Takami T, El-Naggar A, Morino M, Nishio A, Inoue Y, Hakuba A. Posterior approach for cervical intramedullary arteriovenous malformation with diffuse-type nidus. Report of three cases. J Neurosurg. 1999 Jul; 91(1 Suppl):105-11. PMID: 10419354.
      View in: PubMed
    441. Batsakis JG, Suarez P, el-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol. 1999 Jul; 35(4):354-9. PMID: 10645398.
      View in: PubMed
    442. Steck K, Hunt K, Tucker S, Singletary S, El-Naggar AK. Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics. Oncol Rep. 1999 Jul-Aug; 6(4):835-8. PMID: 10373666.
      View in: PubMed
    443. Klijanienko J, el-Naggar AK, Vielh P. Comparative cytologic and histologic study of fifteen salivary basal-cell tumors: differential diagnostic considerations. Diagn Cytopathol. 1999 Jul; 21(1):30-4. PMID: 10405805.
      View in: PubMed
    444. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D, Waugh MK. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999 May 05; 91(9):763-71. PMID: 10328106.
      View in: PubMed
    445. Lovell M, Lott ST, Wong P, El-Naggar A, Tucker S, Killary AM. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. Cancer Res. 1999 May 01; 59(9):2182-9. PMID: 10232606.
      View in: PubMed
    446. Jin YT, Myers J, Tsai ST, Goepfert H, Batsakis JG, el-Naggar AK. Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol. 1999 May; 35(3):251-6. PMID: 10621844.
      View in: PubMed
    447. Delehedde M, Cho SH, Sarkiss M, Brisbay S, Davies M, El-Naggar AK, McDonnell TJ. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer. 1999 Apr 01; 85(7):1514-22. PMID: 10193941.
      View in: PubMed
    448. Evans SC, Foster CJ, El-Naggar AK, Lozano G. Mapping and mutational analysis of the human TAF2G gene encoding a p53 cofactor. Genomics. 1999 Apr 01; 57(1):182-3. PMID: 10191103.
      View in: PubMed
    449. Ohata K, El-Naggar A, Takami T, Morino M, El-Adawy Y, El-Sheik K, Inoue Y, Hakuba A. Efficacy of induced hypotension in the surgical treatment of large cavernous sinus cavernomas. J Neurosurg. 1999 Apr; 90(4):702-8. PMID: 10193616.
      View in: PubMed
    450. Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Cancer Gene Ther. 1999 Mar-Apr; 6(2):163-71. PMID: 10195883.
      View in: PubMed
    451. el-Naggar AK, Klijanienko J. Advances in clinical investigations of salivary gland tumorigenesis. Ann Pathol. 1999 Mar; 19(1):19-22. PMID: 10320906.
      View in: PubMed
    452. Lai S, El-Naggar AK. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lab Invest. 1999 Mar; 79(3):255-60. PMID: 10092061.
      View in: PubMed
    453. Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999 Feb; 125(2):149-52. PMID: 10037280.
      View in: PubMed
    454. el-Naggar AK, Lovell M, Callender DL, Killary AM. Limited nonrandom chromosomal aberrations in a recurrent adenoid cystic carcinoma of the parotid gland. Cancer Genet Cytogenet. 1999 Feb; 109(1):66-9. PMID: 9973962.
      View in: PubMed
    455. Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF. p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol. 1999 Jan; 18(1):29-41. PMID: 9891239.
      View in: PubMed
    456. el-Naggar AK, Lovell M, Callender DL, Ordonez NG, Killary AM. Concurrent cytogenetic, interphase fluorescence in situ hybridization and DNA flow cytometric analyses of a carcinoma ex-pleomorphic adenoma of parotid gland. Cancer Genet Cytogenet. 1998 Dec; 107(2):132-6. PMID: 9844608.
      View in: PubMed
    457. Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 1998 Nov 05; 17(18):2313-22. PMID: 9811462.
      View in: PubMed
    458. Gillenwater A, Jacob R, Ganeshappa R, Kemp B, El-Naggar AK, Palmer JL, Clayman G, Mitchell MF, Richards-Kortum R. Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. Arch Otolaryngol Head Neck Surg. 1998 Nov; 124(11):1251-8. PMID: 9821929.
      View in: PubMed
    459. Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, Fan Y, Zhou X, Clayman G, Lee JJ, Lee JS, Hittelman WN, Lippman SM, Hong WK. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst. 1998 Oct 21; 90(20):1545-51. PMID: 9790547.
      View in: PubMed
    460. Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validire P, Vielh P. Mucoepidermoid carcinoma ex pleomorphic adenoma: nonspecific preoperative cytologic findings in six cases. Cancer. 1998 Aug 25; 84(4):231-4. PMID: 9723598.
      View in: PubMed
    461. Coombes MM, Mao L, Steck KD, Luna MA, El-Naggar AK. Genotypic analysis of flow-sorted and microdissected head and neck squamous lesions by whole-genome amplification. Diagn Mol Pathol. 1998 Aug; 7(4):197-201. PMID: 9917129.
      View in: PubMed
    462. Woods KV, El-Naggar A, Clayman GL, Grimm EA. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res. 1998 Jul 15; 58(14):3132-41. PMID: 9679981.
      View in: PubMed
    463. Batsakis JG, Suarez P, El-Naggar AK. Mucosal melanomas of the head and neck. Ann Otol Rhinol Laryngol. 1998 Jul; 107(7):626-30. PMID: 9682861.
      View in: PubMed
    464. El-Naggar AK, Coombes MM, Batsakis JG, Hong WK, Goepfert H, Kagan J. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene. 1998 Jun 11; 16(23):2983-7. PMID: 9662330.
      View in: PubMed
    465. Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer. 1998 Jun 01; 82(11):2159-65. PMID: 9610695.
      View in: PubMed
    466. Clayman GL, el-Naggar AK, Lippman SM, Henderson YC, Frederick M, Merritt JA, Zumstein LA, Timmons TM, Liu TJ, Ginsberg L, Roth JA, Hong WK, Bruso P, Goepfert H. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Jun; 16(6):2221-32. PMID: 9626224.
      View in: PubMed
    467. Klijanienko J, Servois V, Jammet P, Validire P, Pouillart P, Vielh P, El-Naggar AK, Dulmet E. Pleomorphic adenoma. Am J Surg Pathol. 1998 Jun; 22(6):772-3. PMID: 9630186.
      View in: PubMed
    468. Roberts HL, Komaki R, Allen P, El-Naggar AK. Prognostic significance of DNA content in stage I adenocarcinoma of the lung. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):573-8. PMID: 9635704.
      View in: PubMed
    469. Roth JA, Swisher SG, Merritt JA, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khurl FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol. 1998 Jun; 25(3 Suppl 8):33-7. PMID: 9704675.
      View in: PubMed
    470. Ballo MT, Garden AS, El-Naggar AK, Gillenwater AM, Morrison WH, Goepfert H, Ang KK. Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure. Laryngoscope. 1998 May; 108(5):760-3. PMID: 9591559.
      View in: PubMed
    471. Suarez P, Batsakis JG, el-Naggar AK. Leukoplakia: still a gallimaufry or is progress being made?--A review. Adv Anat Pathol. 1998 May; 5(3):137-55. PMID: 9868520.
      View in: PubMed
    472. Dubey P, Ha CS, Ang KK, El-Naggar AK, Knapp C, Byers RM, Morrison WH. Nonnasopharyngeal lymphoepithelioma of the head and neck. Cancer. 1998 Apr 15; 82(8):1556-62. PMID: 9554534.
      View in: PubMed
    473. Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Clin Cancer Res. 1998 Apr; 4(4):1065-70. PMID: 9563903.
      View in: PubMed
    474. el-Naggar AK, Abdul-Karim FW, Hurr K, Callender D, Luna MA, Batsakis JG. Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. Cancer Genet Cytogenet. 1998 Apr 01; 102(1):19-24. PMID: 9530335.
      View in: PubMed
    475. Byers RM, El-Naggar AK, Lee YY, Rao B, Fornage B, Terry NH, Sample D, Hankins P, Smith TL, Wolf PJ. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck. 1998 Mar; 20(2):138-44. PMID: 9484945.
      View in: PubMed
    476. Soria JC, Vielh P, el-Naggar AK. Telomerase activity in cancer: a magic bullet or a mirage? Adv Anat Pathol. 1998 Mar; 5(2):86-94. PMID: 9868515.
      View in: PubMed
    477. Papadimitrakopoulou VA, Oh Y, El-Naggar A, Izzo J, Clayman G, Mao L. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clin Cancer Res. 1998 Mar; 4(3):539-44. PMID: 9533520.
      View in: PubMed
    478. el-Naggar AK, Lovell M, Ordonez NG, Killary AM. Multiple unrelated translocations in a metastatic epimyoepithelial carcinoma of the parotid gland. Cancer Genet Cytogenet. 1998 Jan 15; 100(2):155-8. PMID: 9428361.
      View in: PubMed
    479. Steck K, el-Naggar A. Simultaneous DNA/RNA analysis of solid and hematoreticular malignancies. Methods Mol Biol. 1998; 91:167-79. PMID: 9664493.
      View in: PubMed
    480. Steck K, el-Naggar A. Solid tumor DNA ploidy analysis. Methods Mol Biol. 1998; 91:181-95. PMID: 9664494.
      View in: PubMed
    481. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA, et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 1997 Dec 01; 57(23):5221-5. PMID: 9393738.
      View in: PubMed
    482. el-Naggar AK, Hurr K, Luna MA, Goepfert H, Hong WK, Batsakis JG. Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers. Diagn Mol Pathol. 1997 Dec; 6(6):305-8. PMID: 9559289.
      View in: PubMed
    483. El-Naggar AK, Lai S, Clayman G, Lee JK, Luna MA, Goepfert H, Batsakis JG. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol. 1997 Dec; 151(6):1767-74. PMID: 9403727.
      View in: PubMed
    484. Gillenwater A, Hurr K, Wolf P, Batsakis JG, Goepfert H, El-Naggar AK. Microsatellite alterations at chromosome 8q loci in pleomorphic adenoma. Otolaryngol Head Neck Surg. 1997 Nov; 117(5):448-52. PMID: 9374165.
      View in: PubMed
    485. Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validire P, Vielh P. Clinically aggressive metastasizing pleomorphic adenoma: report of two cases. Head Neck. 1997 Oct; 19(7):629-33. PMID: 9323153.
      View in: PubMed
    486. de la Roza G, Cleary KR, Ordóñez NG, el-Naggar A, Mackay B, Romsdahl MM. Solid and papillary tumor of the pancreas: ultrastructural observations on two contrasting cases. Ultrastruct Pathol. 1997 Sep-Oct; 21(5):439-47. PMID: 9273974.
      View in: PubMed
    487. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol. 1997 Sep; 158(3 Pt 1):724-8. PMID: 9258068.
      View in: PubMed
    488. Silva EG, Tornos C, Fritsche HA, el-Naggar A, Gray K, Ordonez NG, Luna M, Gershenson D. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol. 1997 Sep; 10(9):879-83. PMID: 9310950.
      View in: PubMed
    489. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997 Aug; 15(8):2894-904. PMID: 9256133.
      View in: PubMed
    490. El-Naggar AK, Dinh M, Tucker SL, Gillenwater A, Luna MA, Batsakis JG. Chromosomal and DNA ploidy characterization of salivary gland neoplasms by combined FISH and flow cytometry. Hum Pathol. 1997 Aug; 28(8):881-6. PMID: 9269822.
      View in: PubMed
    491. Gershenson DM, Baker VV, Price JE, Hung MC, El-Naggar AK, Tortolero-Luna G, Silva EG. Molecular profile of advanced-stage transitional cell carcinoma of the ovary. Am J Obstet Gynecol. 1997 Jul; 177(1):120-5. PMID: 9240594.
      View in: PubMed
    492. Lai S, Benedict WF, Silver SA, El-Naggar AK. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. Hum Pathol. 1997 Jun; 28(6):693-7. PMID: 9191003.
      View in: PubMed
    493. el-Naggar AK, Hurr K, Kagan J, Gillenwater A, Callender D, Luna MA, Batsakis JG. Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surg Pathol. 1997 Jun; 21(6):691-7. PMID: 9199647.
      View in: PubMed
    494. Meterissian SH, Skibber JM, Giacco GG, el-Naggar AK, Hess KR, Rich TA. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery. 1997 May; 121(5):479-87. PMID: 9142144.
      View in: PubMed
    495. Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials. Clin Cancer Res. 1997 Feb; 3(2):185-91. PMID: 9815671.
      View in: PubMed
    496. Cagle PT, el-Naggar AK, Xu HJ, Hu SX, Benedict WF. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Am J Pathol. 1997 Feb; 150(2):393-400. PMID: 9033254.
      View in: PubMed
    497. Suarez P, el-Naggar AK, Batsakis JG. Intracellular crystalline deposits in lymphoplasmacellular disorders. Ann Otol Rhinol Laryngol. 1997 Feb; 106(2):170-2. PMID: 9041825.
      View in: PubMed
    498. Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene. 1997 Jan 23; 14(3):369-73. PMID: 9018123.
      View in: PubMed
    499. Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997 Jan 01; 37(1):79-85. PMID: 9054880.
      View in: PubMed
    500. Pollock RE, Lang A, El-Naggar AK, Radinsky R, Hung MC. Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms. Sarcoma. 1997; 1(1):23-9. PMID: 18521197.
      View in: PubMed
    501. Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman SM, Kayser S, Lotan R, Hong WK. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 1996 Dec 15; 56(24):5600-4. PMID: 8971162.
      View in: PubMed
    502. Batsakis JG, El-Naggar AK, Luna MA. Thyroid gland ectopias. Ann Otol Rhinol Laryngol. 1996 Dec; 105(12):996-1000. PMID: 8973289.
      View in: PubMed
    503. Batsakis JG, Mackay B, el-Naggar AK. Ewing's sarcoma and peripheral primitive neuroectodermal tumor: an interim report. Ann Otol Rhinol Laryngol. 1996 Oct; 105(10):838-43. PMID: 8865780.
      View in: PubMed
    504. Wang RY, Troncoso P, Palmer JL, El-Naggar AK, Liang JC. Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression. Clin Cancer Res. 1996 Sep; 2(9):1553-8. PMID: 9816332.
      View in: PubMed
    505. Gillenwater A, Xu XC, el-Naggar AK, Clayman GL, Lotan R. Expression of galectins in head and neck squamous cell carcinoma. Head Neck. 1996 Sep-Oct; 18(5):422-32. PMID: 8864733.
      View in: PubMed
    506. Torres C, Ro JY, el-Naggar AK, Sim SJ, Weber RS, Ayala AG. Allergic fungal sinusitis: a clinicopathologic study of 16 cases. Hum Pathol. 1996 Aug; 27(8):793-9. PMID: 8760012.
      View in: PubMed
    507. Sastry KJ, Marin MC, Nehete PN, McConnell K, el-Naggar AK, McDonnell TJ. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene. 1996 Aug 01; 13(3):487-93. PMID: 8760290.
      View in: PubMed
    508. Austin JR, el-Naggar AK, Goepfert H. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell. Otolaryngol Clin North Am. 1996 Aug; 29(4):611-27. PMID: 8844733.
      View in: PubMed
    509. Hurr K, Kemp B, Silver SA, el-Naggar AK. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance. Am J Pathol. 1996 Aug; 149(2):613-20. PMID: 8701999.
      View in: PubMed
    510. el-Naggar AK, Lovell M, Killary AM, Batsakis JG. Genotypic characterization of a primary mucoepidermoid carcinoma of the parotid gland by cytogenetic, fluorescence in situ hybridization, and DNA ploidy analysis. Cancer Genet Cytogenet. 1996 Jul 01; 89(1):38-43. PMID: 8689608.
      View in: PubMed
    511. Steck K, McDonnell T, Sneige N, el-Naggar A. Flow cytometric analysis of apoptosis and bcl-2 in primary breast carcinomas: clinical and biological implications. Cytometry. 1996 Jun 01; 24(2):116-22. PMID: 8725660.
      View in: PubMed
    512. Linden MD, el-Naggar AK, Nathanson SD, Jacobson G, Zarbo RJ. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Mod Pathol. 1996 Jun; 9(6):682-9. PMID: 8782208.
      View in: PubMed
    513. Suarez PA, Batsakis JG, El-Naggar AK. Don't confuse dental soft tissues with odontogenic tumors. Ann Otol Rhinol Laryngol. 1996 Jun; 105(6):490-4. PMID: 8638904.
      View in: PubMed
    514. El-Naggar AK, Hurr K, Huff V, Clayman GL, Luna MA, Batsakis JG. Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Am J Pathol. 1996 Jun; 148(6):2067-72. PMID: 8669490.
      View in: PubMed
    515. Eicher SA, Overholt SM, el-Naggar AK, Byers RM, Weber RS. Lower gingival carcinoma. Clinical and pathologic determinants of regional metastases. Arch Otolaryngol Head Neck Surg. 1996 Jun; 122(6):634-8. PMID: 8639295.
      View in: PubMed
    516. Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol. 1996 Jun; 27(6):561-6. PMID: 8666365.
      View in: PubMed
    517. Pollock RE, Lang A, Luo J, El-Naggar AK, Yu D. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. Oncogene. 1996 May 02; 12(9):2035-9. PMID: 8649865.
      View in: PubMed
    518. El-Naggar AK, Hurr K, Huff V, Luna MA, Goepfert H, Batsakis JG. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features. Clin Cancer Res. 1996 May; 2(5):903-7. PMID: 9816248.
      View in: PubMed
    519. Ling YH, el-Naggar AK, Priebe W, Perez-Soler R. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol. 1996 May; 49(5):832-41. PMID: 8622633.
      View in: PubMed
    520. Sneige N, Sahin A, Dinh M, El-Naggar A. Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol. 1996 Apr; 27(4):330-5. PMID: 8617474.
      View in: PubMed
    521. Batsakis JG, El-Naggar AK. Cystic fibrosis and the sinonasal tract. Ann Otol Rhinol Laryngol. 1996 Apr; 105(4):329-30. PMID: 8604900.
      View in: PubMed
    522. Xu X, Stier U, Rosewicz S, Elnaggar A, Lotan R. Selective suppression of nuclear retinoic acid receptor beta gene expression in human pancreatic carcinomas. Int J Oncol. 1996 Mar; 8(3):445-51. PMID: 21544381.
      View in: PubMed
    523. Ligato S, El-Naggar A, Cleary KR, Manning J. Extramedullary plasmacytoma mimicking primary colonic carcinoma in a patient with Crohn's disease. Case report and literature review. Arch Pathol Lab Med. 1996 Mar; 120(3):279-82. PMID: 8629905.
      View in: PubMed
    524. El-Naggar AK, Lovell M, Killary AM, Clayman GL, Batsakis JG. A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality. Cancer Genet Cytogenet. 1996 Mar; 87(1):29-33. PMID: 8646736.
      View in: PubMed
    525. Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE, Evans DB. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg. 1996 Feb; 223(2):154-62. PMID: 8597509.
      View in: PubMed
    526. Janot F, Klijanienko J, Russo A, Mamet JP, de Braud F, El-Naggar AK, Pignon JP, Luboinski B, Cvitkovic E. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer. 1996 Feb; 73(4):531-8. PMID: 8595170.
      View in: PubMed
    527. El-Naggar AK, Kemp BL, Sneige N, Hurr KG, Steck K, Tu ZN, Fritsche HA, Singletary SE, Balch CM. Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content. Clin Cancer Res. 1996 Feb; 2(2):419-26. PMID: 9816186.
      View in: PubMed
    528. el-Naggar AK, Dinh M, Tucker S, Luna MA, Goepfert H, Hsu P, Batsakis JG. Genotypic analysis of primary head and neck squamous carcinoma by combined fluorescence in situ hybridization and DNA flow cytometry. Am J Clin Pathol. 1996 Jan; 105(1):102-8. PMID: 8561074.
      View in: PubMed
    529. Austin JR, Cebrun H, Kershisnik MM, El-Naggar AK, Garden AS, Demonte F, Ginsberg LE, Lippman SM, Goepfert H. Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the m.d. Anderson cancer center. Skull Base Surg. 1996; 6(1):1-8. PMID: 17170947.
      View in: PubMed
    530. Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival. Cancer Res. 1995 Dec 01; 55(23):5693-8. PMID: 7585656.
      View in: PubMed
    531. Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery. 1995 Dec; 118(6):1090-8. PMID: 7491528.
      View in: PubMed
    532. Beckhardt RN, Kiyokawa N, Xi L, Liu TJ, Hung MC, el-Naggar AK, Zhang HZ, Clayman GL. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1995 Nov; 121(11):1265-70. PMID: 7576473.
      View in: PubMed
    533. Rajagopal S, Huang S, Moskal TL, Lee BN, el-Naggar AK, Chakrabarty S. Epidermal growth factor expression in human colon and colon carcinomas: anti-sense epidermal growth factor receptor RNA down-regulates the proliferation of human colon cancer cells. Int J Cancer. 1995 Sep 15; 62(6):661-7. PMID: 7558411.
      View in: PubMed
    534. el-Naggar AK, Steck K, Batsakis JG. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. Cytometry. 1995 Sep 01; 21(1):47-51. PMID: 8529470.
      View in: PubMed
    535. Wojcik EM, Katz RL, Fanning TV, el-Naggar A, Ordonez NG, Johnston D. Diagnosis of mantle cell lymphoma on tissue acquired by fine needle aspiration in conjunction with immunocytochemistry and cytokinetic studies. Possibilities and limitations. Acta Cytol. 1995 Sep-Oct; 39(5):909-15. PMID: 7571969.
      View in: PubMed
    536. Xu XC, el-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol. 1995 Sep; 147(3):815-22. PMID: 7677193.
      View in: PubMed
    537. Kanjilal S, Strom SS, Clayman GL, Weber RS, el-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML, et al. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995 Aug 15; 55(16):3604-9. PMID: 7627969.
      View in: PubMed
    538. el-Naggar AK, Hurr K, Tu ZN, Tucker SL, Swanson D, Hsu PH. Interphase cytogenetics of renal cortical neoplasms. Correlation with DNA ploidy by flow cytometry. Am J Clin Pathol. 1995 Aug; 104(2):141-9. PMID: 7639187.
      View in: PubMed
    539. Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 1995 Jul 15; 55(14):3117-22. PMID: 7606733.
      View in: PubMed
    540. Hsu B, Marin MC, el-Naggar AK, Stephens LC, Brisbay S, McDonnell TJ. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene. 1995 Jul 06; 11(1):175-9. PMID: 7624125.
      View in: PubMed
    541. Cho KJ, el-Naggar AK, Mahanupab P, Luna MA, Batsakis JG. Carcinoma ex-pleomorphic adenoma of the nasal cavity: a report of two cases. J Laryngol Otol. 1995 Jul; 109(7):677-9. PMID: 7561483.
      View in: PubMed
    542. el-Naggar AK, Lai S, Luna MA, Zhou XD, Weber RS, Goepfert H, Batsakis JG. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995 Jun 22; 64(3):196-201. PMID: 7622308.
      View in: PubMed
    543. el-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 1995 Jun 15; 55(12):2656-9. PMID: 7780981.
      View in: PubMed
    544. Batsakis JG, el-Naggar AK, Luna MA. Teratomas of the head and neck with emphasis on malignancy. Ann Otol Rhinol Laryngol. 1995 Jun; 104(6):496-500. PMID: 7771726.
      View in: PubMed
    545. Steck KD, McDonnell TJ, el-Naggar AK. Flow cytometric analysis of apoptosis and bcl-2 in human solid neoplasms. Cytometry. 1995 Jun 01; 20(2):154-61. PMID: 7664626.
      View in: PubMed
    546. el-Kattan I, Redline RW, el-Naggar AK, Grimes MC, Abdul-Karim FW. Cytologic features of intraabdominal desmoplastic small round cell tumor. A case report. Acta Cytol. 1995 May-Jun; 39(3):514-20. PMID: 7539203.
      View in: PubMed
    547. Kemp BL, Batsakis JG, el-Naggar AK, Kotliar SN, Luna MA. Terminal duct adenocarcinomas of the parotid gland. J Laryngol Otol. 1995 May; 109(5):466-8. PMID: 7798011.
      View in: PubMed
    548. Janot F, el-Naggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL. Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer. 1995 Apr 21; 64(2):117-23. PMID: 7615354.
      View in: PubMed
    549. Batsakis JG, el-Naggar AK, Luna MA, Goepfert H. "Inflammatory pseudotumor": what is it? How does it behave? Ann Otol Rhinol Laryngol. 1995 Apr; 104(4 Pt 1):329-31. PMID: 7717628.
      View in: PubMed
    550. Cho KJ, el-Naggar AK, Ordonez NG, Luna MA, Austin J, Batsakis JG. Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene. Am J Clin Pathol. 1995 Apr; 103(4):432-7. PMID: 7726139.
      View in: PubMed
    551. Klijanienko J, el-Naggar AK, de Braud F, Rodriguez-Peralto JL, Rodriguez R, Itzhaki M, Russo A, Janot F, Luboinski B, Cvitkovic E. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer. 1995 Apr 01; 75(7):1649-56. PMID: 8826923.
      View in: PubMed
    552. Roush GR, el-Naggar AK, Abdul-Karim FW. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis. Gynecol Oncol. 1995 Mar; 56(3):430-4. PMID: 7705680.
      View in: PubMed
    553. el-Naggar AK, Hurr K, Tu ZN, Teague K, Raymond KA, Ayala AG, Murray J. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors. Cytometry. 1995 Mar 01; 19(3):256-62. PMID: 7736870.
      View in: PubMed
    554. Hicks MJ, el-Naggar AK, Flaitz CM, Luna MA, Batsakis JG. Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathologic and flow cytometric investigation. Head Neck. 1995 Mar-Apr; 17(2):89-95. PMID: 7558818.
      View in: PubMed
    555. el-Naggar AK, Troncoso P, Ordonez NG. Primary renal carcinoid tumor with molecular abnormality characteristic of conventional renal cell neoplasms. Diagn Mol Pathol. 1995 Mar; 4(1):48-53. PMID: 7735556.
      View in: PubMed
    556. Giannoni C, el-Naggar AK, Ordoñez NG, Tu ZN, Austin J, Luna MA, Batsakis JG. c-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms. Otolaryngol Head Neck Surg. 1995 Mar; 112(3):391-8. PMID: 7870438.
      View in: PubMed
    557. Callender TA, Weber RS, Janjan N, Benjamin R, Zaher M, Wolf P, el-Naggar A. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg. 1995 Feb; 112(2):252-7. PMID: 7838548.
      View in: PubMed
    558. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995 Jan 01; 55(1):1-6. PMID: 7805018.
      View in: PubMed
    559. Marin MC, Hsu B, Meyn RE, Donehower LA, el-Naggar AK, McDonnell TJ. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene. 1994 Nov; 9(11):3107-12. PMID: 7936633.
      View in: PubMed
    560. Pollack A, Zagars GK, el-Naggar AK, Terry NH. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. Urology. 1994 Nov; 44(5):711-8. PMID: 7526527.
      View in: PubMed
    561. Steck K, el-Naggar AK. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry. 1994 Nov 01; 17(3):258-65. PMID: 7851161.
      View in: PubMed
    562. Buzaid A, Legha SS, Balch CM, Ross M, Ring S, Plager C, Papadopoulos NE, el-Naggar AK, Benjamin RS. Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma. Cancer. 1994 Nov 01; 74(9):2476-82. PMID: 7923003.
      View in: PubMed
    563. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, et al. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res. 1994 Nov 01; 54(21):5675-82. PMID: 7522962.
      View in: PubMed
    564. Frankenthaler RA, el-Naggar AK, Ordonez NG, Miller TS, Batsakis JG. High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland. Otolaryngol Head Neck Surg. 1994 Oct; 111(4):460-6. PMID: 7936679.
      View in: PubMed
    565. Batsakis JG, el-Naggar AK, Weber RS. Two perplexing skin tumors: microcystic adnexal carcinoma and keratoacanthoma. Ann Otol Rhinol Laryngol. 1994 Oct; 103(10):829-32. PMID: 7944178.
      View in: PubMed
    566. Zavala-Pompa A, Ro JY, el-Naggar AK, Amin MB, Ordóñez NG, Sella A, Ayala AG. Tubular seminoma. An immunohistochemical and DNA flow-cytometric study of four cases. Am J Clin Pathol. 1994 Oct; 102(4):397-401. PMID: 7524297.
      View in: PubMed
    567. el-Naggar AK, Lovell M, Killary A, Batsakis JG. Trisomy 5 as the sole chromosomal abnormality in a primary mucoepidermoid carcinoma of the minor salivary gland. Cancer Genet Cytogenet. 1994 Sep; 76(2):96-9. PMID: 7923075.
      View in: PubMed
    568. Hicks MJ, el-Naggar AK, Byers RM, Flaitz CM, Luna MA, Batsakis JG. Prognostic factors in mucoepidermoid carcinomas of major salivary glands: a clinicopathologic and flow cytometric study. Eur J Cancer B Oral Oncol. 1994 Sep; 30B(5):329-34. PMID: 7703802.
      View in: PubMed
    569. Batsakis JG, el-Naggar AK, Luna MA. Hyalinizing clear cell carcinoma of salivary origin. Ann Otol Rhinol Laryngol. 1994 Sep; 103(9):746-8. PMID: 8085740.
      View in: PubMed
    570. Chandler D, el-Naggar AK, Brisbay S, Redline RW, McDonnell TJ. Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol. 1994 Aug; 25(8):789-96. PMID: 7520019.
      View in: PubMed
    571. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994 Jul 01; 74(1):152-8. PMID: 8004570.
      View in: PubMed
    572. Clayman GL, Stewart MG, Weber RS, el-Naggar AK, Grimm EA. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg. 1994 Jul; 120(7):743-8. PMID: 8018327.
      View in: PubMed
    573. Batsakis JG, el-Naggar AK. Pseudosarcomatous proliferative lesions of soft tissues. Ann Otol Rhinol Laryngol. 1994 Jul; 103(7):578-82. PMID: 8024223.
      View in: PubMed
    574. Yildiz I, Jaffe N, Aksoy F, el-Naggar AK. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance. Anticancer Res. 1994 May-Jun; 14(3B):1365-9. PMID: 8067707.
      View in: PubMed
    575. Carrillo R, Sneige N, el-Naggar AK. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions. Acta Cytol. 1994 May-Jun; 38(3):367-72. PMID: 8191825.
      View in: PubMed
    576. Ro JY, Guerrieri C, el-Naggar AK, Ordóñez NG, Sorge JG, Ayala AG. Carcinomas metastatic to follicular adenomas of the thyroid gland. Report of two cases. Arch Pathol Lab Med. 1994 May; 118(5):551-6. PMID: 7514864.
      View in: PubMed
    577. Sanchez Y, el-Naggar A, Pathak S, Killary AM. A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. Proc Natl Acad Sci U S A. 1994 Apr 12; 91(8):3383-7. PMID: 8159756.
      View in: PubMed
    578. el-Naggar AK, van Dekken HD, Ensign LG, Pathak S. Interphase cytogenetics in paraffin-embedded sections from renal cortical neoplasms. Correlation with cytogenetic and flow cytometric DNA ploidy analyses. Cancer Genet Cytogenet. 1994 Apr; 73(2):134-41. PMID: 8174088.
      View in: PubMed
    579. Pollack A, Zagars GK, el-Naggar AK, Gauwitz MD, Terry NH. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Cancer. 1994 Apr 01; 73(7):1895-903. PMID: 7511039.
      View in: PubMed
    580. Gauwitz MD, Pollack A, el-Naggar AK, Terry NH, von Eschenbach AC, Zagars GK. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Mar 01; 28(4):821-8. PMID: 8138434.
      View in: PubMed
    581. Heaton KM, el-Naggar A, Ensign LG, Ross MI, Balch CM. Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg. 1994 Feb; 219(2):197-204. PMID: 8129491.
      View in: PubMed
    582. Teague K, el-Naggar A. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Cytometry. 1994 Jan 01; 15(1):21-7. PMID: 7909288.
      View in: PubMed
    583. el-Naggar AK, Pflatz M, Ordóñez NG, Batsakis JG. Tumors of the middle ear and endolymphatic sac. Pathol Annu. 1994; 29 ( Pt 2):199-231. PMID: 7936748.
      View in: PubMed
    584. Mackay B, el-Naggar A, Ordonez NG. Ultrastructure of adrenal cortical carcinoma. Ultrastruct Pathol. 1994 Jan-Apr; 18(1-2):181-90. PMID: 8191624.
      View in: PubMed
    585. Sahin AA, Ro JY, Brown RW, Ordonez NG, Cleary KR, el-Naggar AK, Wilson P, Ayala AG. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. Mod Pathol. 1994 Jan; 7(1):17-22. PMID: 8159647.
      View in: PubMed
    586. Manning JT, Pugh WC, el-Naggar A, Ordóñez NG. Mediastinal lymphoblastic lymphoma with non-lymphoblastic histologic features. Mod Pathol. 1994 Jan; 7(1):59-63. PMID: 8159654.
      View in: PubMed
    587. Heaton KM, Rippon MB, el-Naggar A, Tucker SL, Ross MI, Balch CM. Prognostic implications of DNA index in patients with stage III cutaneous melanoma. Am J Surg. 1993 Dec; 166(6):648-52; discussion 652-3. PMID: 8273843.
      View in: PubMed
    588. el-Naggar AK, Batsakis JG, Wang G, Lee MS. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms. Diagn Mol Pathol. 1993 Dec; 2(4):269-76. PMID: 7906993.
      View in: PubMed
    589. Ro JY, el-Naggar AK, Amin MB, Sahin AA, Ordonez NG, Ayala AG. Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum Pathol. 1993 Nov; 24(11):1203-10. PMID: 7503934.
      View in: PubMed
    590. Ro JY, el-Naggar AK, Amin MB, Ayala AG. Inflammatory pseudotumor of the urinary bladder. Am J Surg Pathol. 1993 Nov; 17(11):1193-4. PMID: 8214267.
      View in: PubMed
    591. Batsakis JG, el-Naggar AK. Wegener's granulomatosis and antineutrophil cytoplasmic autoantibodies. Ann Otol Rhinol Laryngol. 1993 Nov; 102(11):906-8. PMID: 8239356.
      View in: PubMed
    592. Klijanienko J, el-Naggar A, De Braud F, Micheau C, Janot F, Luboinski B, Gentile A, Russo A, Cvitkovic E. Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neck. Anal Quant Cytol Histol. 1993 Oct; 15(5):335-40. PMID: 7505082.
      View in: PubMed
    593. Zavala-Pompa A, Ro JY, el-Naggar A, Ordóñez NG, Amin MB, Pierce PD, Ayala AG. Primary carcinoid tumor of testis. Immunohistochemical, ultrastructural, and DNA flow cytometric study of three cases with a review of the literature. Cancer. 1993 Sep 01; 72(5):1726-32. PMID: 7688660.
      View in: PubMed
    594. Stern SJ, Goepfert H, Clayman G, Byers R, Ang KK, el-Naggar AK, Wolf P. Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol Head Neck Surg. 1993 Sep; 119(9):964-9. PMID: 8357597.
      View in: PubMed
    595. Carrillo R, Batsakis JG, Weber R, Luna MA, el-Naggar AK. Salivary neoplasms of the palate: a flow cytometric and clinicopathological analysis. J Laryngol Otol. 1993 Sep; 107(9):858-61. PMID: 8228611.
      View in: PubMed
    596. Ordóñez NG, Mackay B, el-Naggar AK, Byers RM. Congenital hemangiopericytoma. An ultrastructural, immunocytochemical, and flow cytometric study. Arch Pathol Lab Med. 1993 Sep; 117(9):934-7. PMID: 8368908.
      View in: PubMed
    597. Klijanienko J, el-Naggar A, Ponzio-Prion A, Marandas P, Micheau C, Caillaud JM. Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993 Aug; 119(8):887-90. PMID: 8393682.
      View in: PubMed
    598. Batsakis JG, el-Naggar AK. Papillary neoplasms (Heffner's tumors) of the endolymphatic sac. Ann Otol Rhinol Laryngol. 1993 Aug; 102(8 Pt 1):648-51. PMID: 8352492.
      View in: PubMed
    599. el-Naggar AK, Batsakis JG, Ordóñez NG, Luna MA, Goepfert H. Rhabdomyosarcoma of the adult head and neck: a clinicopathological and DNA ploidy study. J Laryngol Otol. 1993 Aug; 107(8):716-20. PMID: 8409724.
      View in: PubMed
    600. Ordóñez NG, el-Naggar AK, Ro JY, Silva EG, Mackay B. Intra-abdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol. 1993 Aug; 24(8):850-65. PMID: 8375856.
      View in: PubMed
    601. el-Naggar AK, Lee MS, Wang G, Luna MA, Goepfert H, Batsakis JG. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma. Cancer. 1993 Aug 01; 72(3):881-6. PMID: 8101470.
      View in: PubMed
    602. Batsakis JG, el-Naggar AK, Hicks MJ. Epithelial choristomas and teratomas of the tongue. Ann Otol Rhinol Laryngol. 1993 Jul; 102(7):567-9. PMID: 8333680.
      View in: PubMed
    603. McGinnis M, Jacobs G, el-Naggar A, Redline RW. Congenital peribronchial myofibroblastic tumor (so-called "congenital leiomyosarcoma"). A distinct neonatal lung lesion associated with nonimmune hydrops fetalis. Mod Pathol. 1993 Jul; 6(4):487-92. PMID: 8415597.
      View in: PubMed
    604. Wojcik EM, Katz RL, Johnston DA, Sembera D, el-Naggar A. Comparative analysis of DNA ploidy and proliferative index in fine needle aspirates of non-Hodgkin's lymphomas by image analysis and flow cytometry. Anal Quant Cytol Histol. 1993 Jun; 15(3):151-7. PMID: 8347254.
      View in: PubMed
    605. Katz RL, Wojcik EM, el-Naggar AK, Ordonez NG, Johnston DA. Proliferation markers in non-Hodgkin's lymphoma. A comparative study between cytophotometric quantitation of Ki-67 and flow cytometric proliferation index on fine needle aspirates. Anal Quant Cytol Histol. 1993 Jun; 15(3):179-86. PMID: 8347257.
      View in: PubMed
    606. Cajulis RS, Katz RL, Dekmezian R, el-Naggar A, Ro JY. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol. 1993 May-Jun; 37(3):367-72. PMID: 8498138.
      View in: PubMed
    607. Clayman G, Wang SW, Nicolson GL, el-Naggar A, Mazar A, Henkin J, Blasi F, Goepfert H, Boyd DD. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity. Int J Cancer. 1993 Apr 22; 54(1):73-80. PMID: 8386710.
      View in: PubMed
    608. Batsakis JG, Sneige N, el-Naggar AK. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer. Cancer. 1993 Mar 15; 71(6 Suppl):2151-3. PMID: 8443764.
      View in: PubMed
    609. el-Naggar AK, Ro JY, Ensign LG. Papillary renal cell carcinoma: clinical implication of DNA content analysis. Hum Pathol. 1993 Mar; 24(3):316-21. PMID: 8454276.
      View in: PubMed
    610. Ordóñez NG, Mackay B, el-Naggar A, Bannayan GA, Duncan J. Clear cell carcinoid tumour of the stomach. Histopathology. 1993 Feb; 22(2):190-3. PMID: 8454267.
      View in: PubMed
    611. el-Naggar AK, Gaber K, Ordonez NG. Renal cell carcinoma with osteoclast-like giant cells. Virchows Arch A Pathol Anat Histopathol. 1993; 422(5):427-31. PMID: 8322459.
      View in: PubMed
    612. Batsakis JG, Hybels RD, el-Naggar AK. Solitary fibrous tumor. Ann Otol Rhinol Laryngol. 1993 Jan; 102(1 Pt 1):74-6. PMID: 8420474.
      View in: PubMed
    613. Hartwick RW, el-Naggar AK, Ro JY, Srigley JR, McLemore DD, Jones EC, Grignon DJ, Thomas MJ, Ayala AG. Renal oncocytoma and granular renal cell carcinoma. A comparative clinicopathologic and DNA flow cytometric study. Am J Clin Pathol. 1992 Dec; 98(6):587-93. PMID: 1462956.
      View in: PubMed
    614. Batsakis JG, Luna MA, el-Naggar AK. Nonsquamous carcinomas of the larynx. Ann Otol Rhinol Laryngol. 1992 Dec; 101(12):1024-6. PMID: 1463294.
      View in: PubMed
    615. Rodriguez-Peralto JL, el-Naggar AK. Neurothekeoma of the oral cavity: case report and review of the literature. J Oral Maxillofac Surg. 1992 Nov; 50(11):1224-6. PMID: 1403281.
      View in: PubMed
    616. Jacobs JC, Katz RL, Shabb N, el-Naggar A, Ordonez NG, Pugh W. Fine needle aspiration of lymphoblastic lymphoma. A multiparameter diagnostic approach. Acta Cytol. 1992 Nov-Dec; 36(6):887-94. PMID: 1449027.
      View in: PubMed
    617. Batsakis JG, el-Naggar AK. Rhinoscleroma and rhinosporidiosis. Ann Otol Rhinol Laryngol. 1992 Oct; 101(10):879-82. PMID: 1416645.
      View in: PubMed
    618. el-Naggar AK, Pathak S. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms. Anticancer Res. 1992 Sep-Oct; 12(5):1491-500. PMID: 1444211.
      View in: PubMed
    619. Tornos C, Silva EG, el-Naggar A, Burke TW. Aggressive stage I grade 1 endometrial carcinoma. Cancer. 1992 Aug 15; 70(4):790-8. PMID: 1643610.
      View in: PubMed
    620. Voravud N, el-Naggar AK, Balch CM, Theriault RL. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992 Aug; 15(4):365-9. PMID: 1514536.
      View in: PubMed
    621. Graham RA, Teague K, Mclemore D, Cleary K, el-Naggar A. Regional DNA content heterogeneity in colonic adenocarcinoma: prognostic significance in patients with liver metastases. J Surg Oncol. 1992 Aug; 50(4):228-32. PMID: 1640705.
      View in: PubMed
    622. Carrillo R, el-Naggar AK, Rodriguez-Peralto JL, Batsakis JG. Synovial sarcoma of the tongue: case report and review of the literature. J Oral Maxillofac Surg. 1992 Aug; 50(8):904-6. PMID: 1321899.
      View in: PubMed
    623. Batsakis JG, el-Naggar AK, Luna MA. Neuroendocrine tumors of larynx. Ann Otol Rhinol Laryngol. 1992 Aug; 101(8):710-4. PMID: 1323230.
      View in: PubMed
    624. Carrillo R, Rodriquez-Peralto JL, Batsakis JG, el-Naggar AK. Primary haemangiopericytomas of the parotid gland. J Laryngol Otol. 1992 Jul; 106(7):659-61. PMID: 1527469.
      View in: PubMed
    625. Abdul-Karim FW, el-Naggar AK, Joyce MJ, Makley JT, Carter JR. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol. 1992 Jul; 23(7):729-35. PMID: 1319390.
      View in: PubMed
    626. Carrillo R, el-Naggar AK, Luna MA, Rodriguez-Peralto JL, Batsakis JG. Nucleolar organizer regions (NORs) and myoepitheliomas: a comparison with DNA content and clinical course. J Laryngol Otol. 1992 Jul; 106(7):616-20. PMID: 1382110.
      View in: PubMed
    627. El-Naggar AK. DNA flow cytometry in the assessment of solid neoplasms. Ann Saudi Med. 1992 Jul; 12(4):331-3. PMID: 17586988.
      View in: PubMed
    628. el-Naggar AK, Ro JY, McLemore D, Ayala AG, Batsakis JG. DNA ploidy in testicular germ cell neoplasms. Histogenetic and clinical implications. Am J Surg Pathol. 1992 Jun; 16(6):611-8. PMID: 1318004.
      View in: PubMed
    629. Batsakis JG, el-Naggar AK, Luna MA. Epithelial-myoepithelial carcinoma of salivary glands. Ann Otol Rhinol Laryngol. 1992 Jun; 101(6):540-2. PMID: 1376977.
      View in: PubMed
    630. del Giglio A, O'Brien S, Ford R, Saya H, Manning J, Keating M, Johnston D, Khetan R, el-Naggar A, Deisseroth A. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood. 1992 May 15; 79(10):2717-20. PMID: 1350226.
      View in: PubMed
    631. Pollack A, el-Naggar AK, Cox JD, Ro JY, Sahin A, Komaki R. Thymoma. The prognostic significance of flow cytometric DNA analysis. Cancer. 1992 Apr 01; 69(7):1702-9. PMID: 1551054.
      View in: PubMed
    632. el-Naggar AK, Garcia GM. Epithelioid sarcoma. Flow cytometric study of DNA content and regional DNA heterogeneity. Cancer. 1992 Apr 01; 69(7):1721-8. PMID: 1551057.
      View in: PubMed
    633. Gomez R, el-Naggar AK, Byers RM, Garnsey L, Luna MA, Batsakis JG. Squamous carcinoma of oral tongue: prognostic significance of flow-cytometric DNA content. Mod Pathol. 1992 Mar; 5(2):141-5. PMID: 1574491.
      View in: PubMed
    634. el-Naggar A. Laryngeal neuroendocrine carcinoma. Victims of semantics. Arch Pathol Lab Med. 1992 Mar; 116(3):237-8. PMID: 1536607.
      View in: PubMed
    635. Mulhollan TJ, Ro JY, el-Naggar AK, Sahin AA, Ayala AG. Granular cell tumor of the biliary tree. Am J Surg Pathol. 1992 Feb; 16(2):204-6. PMID: 1733352.
      View in: PubMed
    636. Batsakis JG, Sneige N, el-Naggar AK. Fine-needle aspiration of salivary glands: its utility and tissue effects. Ann Otol Rhinol Laryngol. 1992 Feb; 101(2 Pt 1):185-8. PMID: 1739267.
      View in: PubMed
    637. el-Naggar AK, Batsakis JG, Garcia GM, Luna ML, Goepfert H. Sinonasal hemangiopericytomas. A clinicopathologic and DNA content study. Arch Otolaryngol Head Neck Surg. 1992 Feb; 118(2):134-7. PMID: 1540341.
      View in: PubMed
    638. el-Naggar AK, Lopez-Varela V, Luna MA, Weber R, Batsakis JG. Intratumoral DNA content heterogeneity in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1992 Feb; 118(2):169-73. PMID: 1540348.
      View in: PubMed
    639. Mourad WA, Katz RL, Sembera D, Atkinson EN, el-Naggar AK. Two AgNOR counts in fine-needle aspirates of lymphoproliferative disorders compared with acridine orange flow cytometry. Diagn Cytopathol. 1992; 8(2):128-34. PMID: 1568410.
      View in: PubMed
    640. Batsakis JG, el-Naggar AK, Luna MA. "Adenocarcinoma, not otherwise specified": a diminishing group of salivary carcinomas. Ann Otol Rhinol Laryngol. 1992 Jan; 101(1):102-4. PMID: 1728879.
      View in: PubMed
    641. Nashold BS, el-Naggar A, Mawaffak Abdulhak M, Ovelmen-Levitt J, Cosman E. Trigeminal nucleus caudalis dorsal root entry zone: a new surgical approach. Stereotact Funct Neurosurg. 1992; 59(1-4):45-51. PMID: 1295046.
      View in: PubMed
    642. el-Naggar A, Ro JY, Sella A, Ayala AG. Simultaneous renal and transitional cell carcinomas in same kidney with subsequent lymph node metastasis: DNA flow cytometric study. Urology. 1991 Dec; 38(6):585-8. PMID: 1746094.
      View in: PubMed
    643. Grignon DJ, Ro JY, Mackay B, Ordóñez NG, el-Naggar A, Molina TJ, Shum DT, Ayala AG. Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies. Hum Pathol. 1991 Nov; 22(11):1162-9. PMID: 1743702.
      View in: PubMed
    644. Sahin AA, Ro JY, el-Naggar AK, Wilson PL, Teague K, Blick M, Ayala AG. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations. Am J Clin Pathol. 1991 Oct; 96(4):512-9. PMID: 1716414.
      View in: PubMed
    645. Luna MA, Batsakis JG, el-Naggar AK. Salivary gland tumors in children. Ann Otol Rhinol Laryngol. 1991 Oct; 100(10):869-71. PMID: 1659302.
      View in: PubMed
    646. Chan JK, Tsang WY. Intraluminal crystalloids in follicular adenoma of the thyroid. Arch Pathol Lab Med. 1991 Oct; 115(10):974-5. PMID: 1898242.
      View in: PubMed
    647. Sella A, el Naggar A, Ro JY, Dexeus FH, Amato RJ, Lee JS, Finn L, Logothetis CJ. Evidence of malignant features in histologically mature teratoma. J Urol. 1991 Oct; 146(4):1025-8. PMID: 1680200.
      View in: PubMed
    648. el-Naggar AK, Ordonez NG, Garnsey L, Batsakis JG. Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study. Hum Pathol. 1991 Oct; 22(10):972-8. PMID: 1842386.
      View in: PubMed
    649. el-Naggar AK, Abdul-Karim FW, Silva EG, McLemore D, Garnsey L. Uterine stromal neoplasms: a clinicopathologic and DNA flow cytometric correlation. Hum Pathol. 1991 Sep; 22(9):897-903. PMID: 1916750.
      View in: PubMed
    650. Sara A, el-Naggar AK. Intratumoral DNA content variability. A study of non-small cell lung cancer. Am J Clin Pathol. 1991 Sep; 96(3):311-7. PMID: 1652200.
      View in: PubMed
    651. Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer. 1991 Aug 01; 68(3):549-57. PMID: 1648433.
      View in: PubMed
    652. Batsakis JG, Luna MA, el-Naggar AK. Basaloid monomorphic adenomas. Ann Otol Rhinol Laryngol. 1991 Aug; 100(8):687-90. PMID: 1872522.
      View in: PubMed
    653. el-Naggar AK, Batsakis JG, Vassilopoulou-Sellin R, Ordonez NG, Luna MA. Medullary (thyroid) carcinoma-like carcinoids of the larynx. J Laryngol Otol. 1991 Aug; 105(8):683-6. PMID: 1919332.
      View in: PubMed
    654. Ordóñez NG, El-Naggar AK, Hickey RC, Samaan NA. Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. Am J Clin Pathol. 1991 Jul; 96(1):15-24. PMID: 1712540.
      View in: PubMed
    655. el-Naggar AK, Evans DB, Mackay B. Oncocytic adrenal cortical carcinoma. Ultrastruct Pathol. 1991 Jul-Oct; 15(4-5):549-56. PMID: 1755111.
      View in: PubMed
    656. Walts AE. Intracystic papillary carcinoma of the breast. Am J Clin Pathol. 1991 Jun; 95(6):901. PMID: 2042601.
      View in: PubMed
    657. el-Naggar AK, Ballance W, Karim FW, Ordóñez NG, McLemore D, Giacco GG, Batsakis JG. Typical and atypical bronchopulmonary carcinoids. A clinicopathologic and flow cytometric study. Am J Clin Pathol. 1991 Jun; 95(6):828-34. PMID: 2042593.
      View in: PubMed
    658. Robey-Cafferty SS, el-Naggar AK, Sahin AA, Bruner JM, Ro JY, Cleary KR. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol. 1991 Jun; 95(6):844-9. PMID: 2042594.
      View in: PubMed
    659. Connelly JH, Robey-Cafferty SS, el-Naggar AK, Cleary KR. Exophytic signet-ring cell carcinoma of the colorectum. Arch Pathol Lab Med. 1991 May; 115(5):427. PMID: 1850587.
      View in: PubMed
    660. el-Naggar AK, Ordóñez NG, Sara A, McLemore D, Batsakis JG. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications. Cancer. 1991 Apr 15; 67(8):2173-9. PMID: 2004337.
      View in: PubMed
    661. Frauenhoffer EE, Ro JY, el-Naggar AK, Ordóñez NG, Ayala AG. Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. Am J Clin Pathol. 1991 Apr; 95(4):446-53. PMID: 1707587.
      View in: PubMed
    662. Batsakis JG, el-Naggar AK. Terminal duct adenocarcinomas of salivary tissues. Ann Otol Rhinol Laryngol. 1991 Mar; 100(3):251-3. PMID: 2006826.
      View in: PubMed
    663. Sneige N, Dekmezian R, el-Naggar A, Manning J. Cytomorphologic, immunocytochemical, and nucleic acid flow cytometric study of 50 lymph nodes by fine-needle aspiration. Comparison with results obtained by subsequent excisional biopsy. Cancer. 1991 Feb 15; 67(4):1003-7. PMID: 1991247.
      View in: PubMed
    664. Shabb N, Katz R, Ordonez N, Goodacre A, Hirsch-Ginsberg C, el-Naggar A. Fine-needle aspiration evaluation of lymphoproliferative lesions in human immunodeficiency virus-positive patients. A multiparameter approach. Cancer. 1991 Feb 15; 67(4):1008-18. PMID: 1991248.
      View in: PubMed
    665. Connelly JH, Robey-Cafferty SS, el-Naggar AK, Cleary KR. Exophytic signet-ring cell carcinoma of the colorectum. Arch Pathol Lab Med. 1991 Feb; 115(2):134-6. PMID: 1847034.
      View in: PubMed
    666. Ro JY, Sahin AA, el-Naggar AK, Ordonez NG, Mackay B, Llamas LL, Ayala AG. Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study. Arch Pathol Lab Med. 1991 Feb; 115(2):145-9. PMID: 1992980.
      View in: PubMed
    667. el-Naggar AK, Ordonez NG, Batsakis JG. Parotid gland plasmacytoma with crystalline deposits. Oral Surg Oral Med Oral Pathol. 1991 Feb; 71(2):206-8. PMID: 1848362.
      View in: PubMed
    668. Frauenhoffer EE, Ro JY, Silva EG, el-Naggar A. Well-differentiated serous ovarian carcinoma presenting as a breast mass: a case report and flow cytometric DNA study. Int J Gynecol Pathol. 1991; 10(1):79-87. PMID: 2007537.
      View in: PubMed
    669. Ro JY, Dexeus FH, el-Naggar A, Ayala AG. Testicular germ cell tumors. Clinically relevant pathologic findings. Pathol Annu. 1991; 26 Pt 2:59-87. PMID: 1650448.
      View in: PubMed
    670. el-Naggar AK, Batsakis JG, Teague K, Garnsey L, Barlogie B. Single- and double-stranded RNA measurements by flow cytometry in solid neoplasms. Cytometry. 1991; 12(4):330-5. PMID: 2065558.
      View in: PubMed
    671. Detweiler RE, Katz RL, Alapat C, el-Naggar A, Ordóñez N. Malignant lymphoma of the thyroid: a report of two cases diagnosed by fine-needle aspiration. Diagn Cytopathol. 1991; 7(2):163-71. PMID: 2065571.
      View in: PubMed
    672. el-Naggar AK, Batsakis JG. Carcinoid tumor of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec. 1991; 53(4):188-93. PMID: 1891251.
      View in: PubMed
    673. Loose JH, el-Naggar AK, Ro JY, Huang WL, McMurtrey MJ, Ayala AG. Primary osteosarcoma of the lung. Report of two cases and review of the literature. J Thorac Cardiovasc Surg. 1990 Dec; 100(6):867-73. PMID: 2246908.
      View in: PubMed
    674. el-Naggar AK, Ordonez NG, McLemore D, Schultz P, Hickey RC, Samaan N. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma. Surgery. 1990 Dec; 108(6):981-5. PMID: 2247844.
      View in: PubMed
    675. Batsakis JG, Luna MA, el-Naggar A. Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol. 1990 Dec; 99(12):1007-9. PMID: 2173892.
      View in: PubMed
    676. Sahin AA, Ro JY, Ordoñez NG, Luna MA, el-Naggar AK, Goepfert H, Ayala AG. Myofibroblastoma of the tongue. An immunohistochemical, ultrastructural, and flow cytometric study. Am J Clin Pathol. 1990 Dec; 94(6):773-7. PMID: 1700879.
      View in: PubMed
    677. Corkill ME, Sneige N, Fanning T, el-Naggar A. Fine-needle aspiration cytology and flow cytometry of intracystic papillary carcinoma of breast. Am J Clin Pathol. 1990 Dec; 94(6):673-80. PMID: 2244588.
      View in: PubMed
    678. Sara AS, Ayala AG, el-Naggar A, Ro JY, Raymond AK, Murray JA. Giant cell tumor of bone. A clinicopathologic and DNA flow cytometric analysis. Cancer. 1990 Nov 15; 66(10):2186-90. PMID: 2224773.
      View in: PubMed
    679. Luna MA, el-Naggar A, Batsakis JG, Weber RS, Garnsey LA, Goepfert H. Flow cytometric DNA content of adenoid cystic carcinoma of submandibular gland. Correlation of histologic features and prognosis. Arch Otolaryngol Head Neck Surg. 1990 Nov; 116(11):1291-6. PMID: 2173619.
      View in: PubMed
    680. Batsakis JG, Luna MA, el-Naggar AK. Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol. 1990 Nov; 99(11):929-33. PMID: 2241022.
      View in: PubMed
    681. Tornos C, Silva E, el-Naggar A, Pritzker KP. Calcium oxalate crystals in breast biopsies. The missing microcalcifications. Am J Surg Pathol. 1990 Oct; 14(10):961-8. PMID: 1698342.
      View in: PubMed
    682. Ro JY, Ayala AG, Tetu B, Ordonez NG, el-Naggar A, Grignon DJ, Mackay B. Merkel cell carcinoma metastatic to the testis. Am J Clin Pathol. 1990 Oct; 94(4):384-9. PMID: 1699405.
      View in: PubMed
    683. el-Naggar AK, Batsakis JG, Teague K, Giacco G, Guinee VF, Swanson D. Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content. Am J Pathol. 1990 Aug; 137(2):275-80. PMID: 2386196.
      View in: PubMed
    684. Luna MA, el Naggar A, Parichatikanond P, Weber RS, Batsakis JG. Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer. 1990 Aug 01; 66(3):537-42. PMID: 2364364.
      View in: PubMed
    685. El-Naggar AK, Mackay B, Sneige N, Batsakis JG. Stromal neoplasms of the breast: a comparative flow cytometric study. J Surg Oncol. 1990 Jul; 44(3):151-6. PMID: 2164618.
      View in: PubMed
    686. Batsakis JG, el-Naggar AK. Warthin's tumor. Ann Otol Rhinol Laryngol. 1990 Jul; 99(7 Pt 1):588-91. PMID: 2195965.
      View in: PubMed
    687. Ballance WA, Ro JY, el-Naggar AK, Grignon DJ, Ayala AG, Romsdahl MG. Pleomorphic adenoma (benign mixed tumor) of the breast. An immunohistochemical, flow cytometric, and ultrastructural study and review of the literature. Am J Clin Pathol. 1990 Jun; 93(6):795-801. PMID: 2161180.
      View in: PubMed
    688. el-Naggar AK, Ayala AG, Abdul-Karim FW, McLemore D, Ballance WW, Garnsey L, Ro JY, Batsakis JG. Synovial sarcoma. A DNA flow cytometric study. Cancer. 1990 May 15; 65(10):2295-300. PMID: 2161280.
      View in: PubMed
    689. Batsakis JG, el-Naggar AK. Sebaceous lesions of salivary glands and oral cavity. Ann Otol Rhinol Laryngol. 1990 May; 99(5 Pt 1):416-8. PMID: 2337322.
      View in: PubMed
    690. Robey-Cafferty SS, el-Naggar AK, Grignon DJ, Cleary KR, Ro JY. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum. Mod Pathol. 1990 May; 3(3):261-6. PMID: 2362936.
      View in: PubMed
    691. el-Naggar AK, Batsakis JG, Luna MA, McLemore D, Byers RM. DNA flow cytometry of acinic cell carcinomas of major salivary glands. J Laryngol Otol. 1990 May; 104(5):410-6. PMID: 2370468.
      View in: PubMed
    692. el-Naggar AK, Ro JY, McLemore D, Garnsy L. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance. Am J Clin Pathol. 1990 Apr; 93(4):480-5. PMID: 2157332.
      View in: PubMed
    693. Grignon DJ, Ayala AG, Ro JY, el-Naggar A, Papadopoulos NJ. Primary sarcomas of the kidney. A clinicopathologic and DNA flow cytometric study of 17 cases. Cancer. 1990 Apr 01; 65(7):1611-8. PMID: 2155701.
      View in: PubMed
    694. Sahin AA, Ro JY, el-Naggar AK, Lee JS, Ayala AG, Teague K, Hong WK. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung. Cancer. 1990 Feb 01; 65(3):530-7. PMID: 2153432.
      View in: PubMed
    695. Shetlar DJ, Font RL, Ordóñez N, el-Naggar A, Boniuk M. A clinicopathologic study of three carcinoid tumors metastatic to the orbit. Immunohistochemical, ultrastructural, and DNA flow cytometric studies. Ophthalmology. 1990 Feb; 97(2):257-64. PMID: 2109298.
      View in: PubMed
    696. McLemore DD, el Naggar A, Stephens LC, Jardine JH. Modified methodology to improve flow cytometric DNA histograms from paraffin-embedded material. Stain Technol. 1990; 65(6):279-91. PMID: 2080523.
      View in: PubMed
    697. Ro JY, Ayala AG, el-Naggar A, Grignon DJ, Hogan SF, Howard DR. Angiomyolipoma of kidney with lymph node involvement. DNA flow cytometric analysis. Arch Pathol Lab Med. 1990 Jan; 114(1):65-7. PMID: 2294869.
      View in: PubMed
    698. Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G. c-erbB-2 amplification in node-negative human breast cancer. Cancer Res. 1989 Dec 15; 49(24 Pt 1):6941-4. PMID: 2573424.
      View in: PubMed
    699. el-Naggar A, Batsakis JG, Luna MA, Goepfert H, Tortoledo ME. DNA content and proliferative activity of myoepitheliomas. J Laryngol Otol. 1989 Dec; 103(12):1192-7. PMID: 2559135.
      View in: PubMed
    700. Grignon DJ, Ayala AG, el-Naggar A, Wishnow KI, Ro JY, Swanson DA, McLemore D, Giacco GG, Guinee VF. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Cancer. 1989 Nov 15; 64(10):2133-40. PMID: 2804902.
      View in: PubMed
    701. el-Naggar AK, Ro JY, Ayala AG, Ward R, Ordóñez NG. Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study. Am J Clin Pathol. 1989 Nov; 92(5):561-5. PMID: 2479254.
      View in: PubMed
    702. Grignon DJ, el-Naggar A, Ro JY, Johnson DE, Ayala AG. Deoxyribonucleic acid flow cytometry on primary adenocarcinoma of the bladder: an analysis of 36 cases. J Urol. 1989 Nov; 142(5):1206-10. PMID: 2810494.
      View in: PubMed
    703. Batsakis JG, el Naggar A. Basaloid-squamous carcinomas of the upper aerodigestive tracts. Ann Otol Rhinol Laryngol. 1989 Nov; 98(11):919-20. PMID: 2817687.
      View in: PubMed
    704. Batsakis JG, Regezi JA, Luna MA, el-Naggar A. Histogenesis of salivary gland neoplasms: a postulate with prognostic implications. J Laryngol Otol. 1989 Oct; 103(10):939-44. PMID: 2685148.
      View in: PubMed
    705. el-Naggar AK, Ro JY, McLemore D, Garnsey L, Ordonez N, MacKay B. Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least five years of follow-up. Mod Pathol. 1989 Sep; 2(5):511-5. PMID: 2554282.
      View in: PubMed
    706. Grignon DJ, el-Naggar A, Green LK, Ayala AG, Ro JY, Swanson DA, Troncoso P, McLemore D, Giacco GG, Guinee VF. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma. Cancer. 1989 Mar 15; 63(6):1161-5. PMID: 2917319.
      View in: PubMed
    707. Robey SS, Silva EG, Gershenson DM, McLemore D, el-Naggar A, Ordonez NG. Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy. Cancer. 1989 Mar 01; 63(5):839-47. PMID: 2644014.
      View in: PubMed
    708. el-Naggar AK, Ro JY, Ayala AG, Hinchey WW, Abdul-Karim FW, Batsakis JG. Angiomatoid malignant fibrous histiocytoma: flow cytometric DNA analysis of six cases. J Surg Oncol. 1989 Mar; 40(3):201-4. PMID: 2537444.
      View in: PubMed
    709. Weber RS, Palmer JM, el-Naggar A, McNeese MD, Guillamondegui OM, Byers RM. Minor salivary gland tumors of the lip and buccal mucosa. Laryngoscope. 1989 Jan; 99(1):6-9. PMID: 2535883.
      View in: PubMed
    710. Rutledge ML, Silva EG, McLemore D, El-Naggar A. Serous surface carcinoma of the ovary and peritoneum. A flow cytometric study. Pathol Annu. 1989; 24 Pt 2:227-35. PMID: 2771453.
      View in: PubMed
    711. el-Naggar A, Batsakis JG, Kessler S. Benign metastatic mixed tumours or unrecognized salivary carcinomas? J Laryngol Otol. 1988 Sep; 102(9):810-2. PMID: 2844940.
      View in: PubMed
    712. Ro JY, el-Naggar A, Ayala AG, Mody DR, Ordóñez NG. Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol. 1988 Jun; 12(6):453-60. PMID: 2454036.
      View in: PubMed
    713. el-Naggar AK, Batsakis JG, Luna MA, Hickey RC. Hürthle cell tumors of the thyroid. A flow cytometric DNA analysis. Arch Otolaryngol Head Neck Surg. 1988 May; 114(5):520-1. PMID: 3355687.
      View in: PubMed
    714. el-Naggar A, Abdul-Karim FW, Marshalleck JJ, Sorensen K. Fine-needle aspiration of fibromatosis of the breast. Diagn Cytopathol. 1987 Dec; 3(4):320-2. PMID: 3428067.
      View in: PubMed
    715. Ro JY, Ayala AG, el-Naggar A, Wishnow KI. Seminal vesicle involvement by in situ and invasive transitional cell carcinoma of the bladder. Am J Surg Pathol. 1987 Dec; 11(12):951-8. PMID: 3688301.
      View in: PubMed
    716. Ro JY, Ayala AG, el-Naggar A. Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol. 1987 Sep; 11(9):668-73. PMID: 3631381.
      View in: PubMed
    717. Van Epps DE, El-Naggar A, Ochs HD. Abnormalities of lymphocyte locomotion in immunodeficiency disease. Clin Exp Immunol. 1983 Sep; 53(3):679-88. PMID: 6616960.
      View in: PubMed
    718. Wongmongkolrit T, McPherson SL, El-Naggar A, Hafner R, Codispoti V, Schnall A, Jackson DL, Bonstelle C. Acute fulminant toxoplasma meningoencephalitis in a homosexual man. Acta Neuropathol. 1983; 60(3-4):305-8. PMID: 6613539.
      View in: PubMed
    719. El-Naggar A, Van Epps DE, Williams RC. A human lymphocyte chemotactic factor produced by the mixed lymphocyte reaction. J Lab Clin Med. 1982 Oct; 100(4):558-65. PMID: 6214599.
      View in: PubMed
    720. El Naggar A, Colley DG. Modulation of schistosoma mansoni egg-induced granuloma formation. II. Soluble suppressor activity from lymphoid cels during chronic infection. Cell Immunol. 1982 Sep 01; 72(1):151-6. PMID: 6890878.
      View in: PubMed
    721. El-Naggar AK, Higashi GI. In vivo and in vitro cell-mediated immunity in tuberculous meningitis. J Clin Lab Immunol. 1982 May; 8(1):37-42. PMID: 7047745.
      View in: PubMed
    722. El-Naggar A, Van Epps DE, Williams RC. Effect of culturing on the human lymphocyte locomotion response to casein, C5a, and fMet-Leu-Phe. Cell Immunol. 1981 May 01; 60(1):43-9. PMID: 7237565.
      View in: PubMed
    723. El-Naggar A, Higashi GI. Tuberculous meningitis: E-rosette-forming T lymphocytes in cerebrospinal fluid. Neurology. 1981 May; 31(5):610-2. PMID: 6972016.
      View in: PubMed
    724. El-Naggar AK, Van Epps DE, Williams RC. Human-B and T-lymphocyte locomotion in response to casein, C5a, and f-met-leu-phe. Cell Immunol. 1980 Dec; 56(2):365-73. PMID: 6970626.
      View in: PubMed
    725. Reiner NE, Kamel R, Higashi GI, el-Naggar A, Aguib M, Ellner JJ, Mahmoud AA. Concurrent responses of peripheral blood and splenic mononuclear cells to antigenic and mitogenic stimulation in human hepatosplenic schistosomiasis. J Infect Dis. 1979 Aug; 140(2):162-8. PMID: 314479.
      View in: PubMed
    726. Kamel K, 'Umar M, Ibrahim W, Mansour A, Gaballah F, Selim O, Azim A, Hamza S, Sabry F, Moafy N, El-naggar A, Hoerman K. Anthropological studies among Libyans. Erythrocyte genetic factors, serum haptoglobin phenotypes and anthropometry. Am J Phys Anthropol. 1975 Jul; 43(1):103-11. PMID: 808138.
      View in: PubMed
    727. Ibrahim WN, Kamel K, Selim O, Azim A, Gaballah MF, Sabry F, el-Naggar A, Hoerman K. Hereditary blood factors and anthropometry of the inhabitants of the Egyptian Siwa Oasis. Hum Biol. 1974 Feb; 46(1):57-68. PMID: 4426595.
      View in: PubMed
    728. el-Refai A, el-Naggar A. Utilisation of preserved human sclera in retinal detachment surgery. Bull Ophthalmol Soc Egypt. 1972; 65(69):407-13. PMID: 4666797.
      View in: PubMed
    729. Gad-el-Mawla N, el-Naggar A, Hafez S, Abdallah A. The bilharzial liver and irradiation. J Egypt Med Assoc. 1971; 54(4):190-6. PMID: 5139998.
      View in: PubMed
    730. Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients. Cancer Research. 75:1205-1215.
    731. Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies (Journal of Clinical Endocrinology and Metabolism (2011) 96, (997-1005)). Journal of Clinical Endocrinology and Metabolism. 97:1399.
    732. Primary intraosseous mucoepidermoid carcinoma of the jaw. Head and Neck.
    733. Reirradiation of head and neck cancers with intensity modulated radiation therapy. International Journal of Radiation Oncology Biology Physics. 95:1117-1131.
    734. Tumors of the salivary glands. 761-794.
    735. Flow cytometric analysis of ovarian adult type granulosa cell tumors. Turkish Journal of Cancer. 29:164-170.
    736. Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the Breast. Breast Diseases. 19:144-145.
    737. Molecular diagnostics of head and neck cancer. 25-50.
    738. Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma. Oral Oncology. 66:38-45.
    739. DNA flow cytometric analysis in the assessment of soft-tissue neoplasms. Cancer Bulletin. 45:24-28.
    740. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head and Neck.
    741. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nature Genetics. 48:265-272.
    742. Commentary. Head and Neck. 31:232-233.
    743. Salivary gland cancer. Expert Review of Endocrinology and Metabolism. 7:479-481.
    744. Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV-negative head and neck cancer. Clinical Cancer Research. 22:4643-4650.
    745. Evolutionary action score of TP53 identifies high-risk mutations associated with decreased survival and increased distant metastases in head and neck cancer. Cancer Research. 75:1527-1536.
    746. DNA ploidy in hepatic cirrhosis, dysplasia and carcinoma. Oncology Reports. 4:443-445.
    747. Corrigendum to Tumor biomarkers in lung cancer. Lung Cancer. 81:497.
    748. Immune Profiling of Adenoid Cystic Carcinoma. Cancer immunology research. 4:679-687.
    749. In Vivo fiber confocal microscopy for detection of oral cavity neoplasia.
    750. Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. Oral Oncology. 51:1120-1125.
    751. Near real time confocal imaging of dysplasia in the oral cavity. 982-983.
    752. Modified methodology to improve flow cytometric dna histograms from paraffin-embedded material. Biotechnic and Histochemistry. 65:279-291.
    753. Erlotinib and the risk of oral cancer the erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial. JAMA oncology. 2:209-216.
    754. Pathology consultation cystic fibrosis and the sinonasal tract. Annals of Otology, Rhinology and Laryngology. 105:329-330.
    755. Genetic variants in DNA double-strand break repair genes and risk of salivary gland carcinoma. PLoS One. 10.
    756. Erratum. Nature Genetics. 33:430.
    757. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Practical Radiation Oncology.
    758. Local and systemic strategies for gene replacement for cancer. British Journal of Cancer. 78:142.
    759. Head and neck. 121-215.
    760. Commentary. Journal of Surgical Oncology. 81:184.
    761. Pseudosarcomatous fibromyxoid tumor of the prostate. American Journal of Clinical Pathology. 96:253-258.
    762. Extraskeletal osteosarcoma of the pleura. American Journal of Roentgenology. 180:972.
    763. Genotypic and phenotypic alterations of p53 in head and neck squamous cell carcinoma. Oncology Reports. 2:1115-1120.
    764. Clinical relevance of the flow cytometric analysis in cancer. Cancer Journal. 5:321-327.
    765. Malignant melanoma metastatic to gastrointestinal tract. A clinicopathologic study. International Journal of Surgical Pathology. 2:3-10.
    766. Molecular diagnostics of head and neck cancer. 417-433.
    767. Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies (Journal of Clinical Endocrinology and Metabolism (2011) 96, 997-1005). Journal of Clinical Endocrinology and Metabolism. 96:2286.
    768. IL-2 receptor expression and Ki-67 flow cytometic analysis in B-chronic lymphocytic leukemia. International Journal of Oncology. 7:1433-1436.
    769. CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
    770. Successful biochemoprevention in a patient with multiple aerodigestive malignancies. International Journal of Cancer Prevention. 2:297-300.
    771. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head and Neck.
    772. A novel target for oral cancer chemoprevention? Notch quite, yet.. Cancer Prevention Research. 8:262-265.
    773. Erratum. Cancer Research. 64:9230.
    774. Early detection and diagnosis of oral premalignant squamous mucosal lesions. 601-617.
    775. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncology. 56:47-53.
    776. Novel t(1;3)(q21,p21) translocation in a basal cell adenocarcinoma of the parotid gland. Human Pathology. 54:189-192.
    777. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prevention Research. 8:1027-1035.
    778. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head and Neck. 37:644-649.
    779. Brain metastasis initial presentation of breast cancer. Breast Disease. 3:35-38.
    780. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biology and Therapy. 16:834-838.
    781. Juvenile granulosa cell tumor of the ovary. International Journal of Oncology. 7:661-665.
    782. Reply. Human Pathology. 25:109-110.
    783. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head and Neck.
    784. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clinical Cancer Research. 22:725-733.
    785. Erratum to "Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma" [Hum Pathol 40 (2009) 827-833] (DOI. Human Pathology. 40:1212.
    786. Diagnostic molecular pathology technology. Seminars in Diagnostic Pathology. 19:55.
    787. Improvement of clinical response and biomarkers by Camellia sinensis (green tea) extract in patients with high-risk oral premalignant lesions. Focus on Alternative and Complementary Therapies. 15:122-123.
    788. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas. Head and Neck.
    789. Multispectral and hyperspectral in vivo imaging of the oral cavity for neoplastic tissue detection.
    790. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma. International Journal of Radiation Oncology Biology Physics.
    791. Fibrous dysplasia - A case of spontaneous involution. Cancer Bulletin. 46:365-368.
    792. Pathologic remission of invasive thymoma after induction chemotherapy. Cancer Bulletin. 44:346-348.
    793. The clinical relevance and assessment of apoptotic cell death. Advances in Anatomic Pathology. 3:205-211.
    794. Erratum. Cancer. 118:2560.
    795. Wide-field and high-resolution optical imaging for early detection of oral neoplasia.
    796. P53 alterations show significant correlation with gene amplification and high S-phase index in breast cancer. International Journal of Oncology. 6:955-962.
    EL-NAGGAR's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description